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Abstract
Chronic obstructive pulmonary disease (COPD) leads to persistent airflow limitation, causing
a large burden to patients and the health care system. Thoracic CT provides an opportunity to
observe the structural pathophysiology of COPD, whereas hyperpolarized gas MRI provides
images of the consequential ventilation heterogeneity. However, hyperpolarized gas MRI is
currently limited to research centres, due to the high cost of gas and polarization equipment.
Therefore, I developed a pipeline using texture analysis and machine learning methods to
create predicted ventilation maps based on non-contrast enhanced, single-volume thoracic CT.
In a COPD cohort, predicted ventilation maps were qualitatively and quantitatively related to
ground-truth MRI ventilation, and both maps were related to important patient lung function
and quality-of-life measures. This study is the first to demonstrate the feasibility of predicting
hyperpolarized MRI-based ventilation from single-volume, breath-hold thoracic CT, which
has potential to translate pulmonary ventilation information to widely available thoracic CT
imaging.
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CHAPTER 1

1

INTRODUCTION

Chronic obstructive pulmonary disease (COPD) is a disease characterized as nonreversible airflow limitation, which causes the lung to be heterogeneously ventilated.
Hyperpolarized gas magnetic resonance imaging (MRI) provides the ability to image the
ventilation within the lung, however is limited to research centres, whereas thoracic
computed tomography (CT) is widely available. In this thesis, the underlying hidden and
visible structural information within CT images was quantified with texture analysis and
machine learning to predict pulmonary ventilation heterogeneity.

Motivation and Rationale
Chronic obstructive pulmonary disease (COPD) is defined by irreversible airflow
obstruction, and presents a serious burden to the health care system and to patients’ quality
of life. COPD was projected to become the third leading cause of by 2030,1 however has
surpassed the projections and was recently reported to already be the third leading cause of
death worldwide.2 As of now there is no cure for COPD,3 instead the current management
goal is to improve health status, prevent exacerbations and prevent related complications
and mortality.3 Figure 1-1 displays the burden of hospitalizations from patients with COPD
in Canada. Importantly, a large portion of patients are admitted for multiple hospital visits
compared to other diseases responsible for large numbers of hospitalizations.4 Related to
these hospitalization statistics, there is a mean annual COPD-related healthcare cost per
patient of over $3000.5

1

Figure 1-1: Leading causes of hospitalizations in Canada.
Figure adapted from Canadian Institute of Health Information, Health Indicators 2008
report.4
The large, and growing, burden illustrates the sub-optimal management and treatment of
COPD. Current measures of lung function include relatively simple and inexpensive
pulmonary function tests. Despite their wide use, these tests provide only a global measure
to encapsulate the complex heterogeneity of the disease, which manifests itself in many
ways including airway obstruction, parenchymal destruction and related pathophysiology
such as vascular abnormalities. Further, COPD is a heterogeneous disease, and does not
affect the entire lung uniformly. A more precise and sensitive method for characterizing
and monitoring underlying structural abnormalities, and resulting functional consequences,
in COPD is needed. This has motivated the use of pulmonary imaging to enable a regional
understanding of underlying structural abnormalities in patient populations, as well as on
an individual level.
Since the late 1970s, x-ray computed tomography (CT) has been used for pulmonary exams
in COPD, specifically for detecting parenchymal destruction, or emphysema.6-10 CT has
further been used to visualize the airways and vasculature within the lung. Alternatively,
emerging imaging technologies such as hyperpolarized gas magnetic resonance imaging
(MRI) have been developed that allow visualization of ventilation heterogeneity within the
2

lung that is a result of underlying structural abnormalities. Hyperpolarized gas MRI
provides unique information on lung function and patient outcomes, however this
functional information is currently limited to a number of research centres of excellence.
To translate this unique information, this thesis focuses on predicting regional ventilation
heterogeneity based on structural patterns and determinants as quantified within widely
available thoracic CT.
In this chapter, background relevant to the understanding and motivation of the original
research work presented in Chapters 2 and 3, is provided. In (1.2), an overview of the
relationship between structure and function of the lung is presented. Section (1.3) presents
the pathophysiology of COPD, followed by the clinical measures (1.4) and current imaging
techniques (1.5) used to monitor COPD. Texture analysis of medical images and the current
role it plays in lung imaging will be introduced in (1.6). Finally, the hypothesis and
objectives of the thesis will be introduced and stated in (1.7).

Structure and Function of the Lung
The lung is a complex organ that allows for efficient distribution and exchange of oxygen
into the bloodstream. The structure of the lungs consists of the airways, parenchyma and
vasculature, while the function is how these components exist together to distribute oxygen
throughout the lung and deliver it into the bloodstream.

1.2.1

Airways

The airways are the highway for delivery of oxygen, and range widely in size and structure.
A diagram of the entire airway tree is shown in Figure 1-2. The beginning airway
generations, including the trachea and the main bronchi, have a large diameter and are
supported by cartilage. As the airway generation increases, the number of airways grows
exponentially due to branching, while the airway diameter decreases. At the terminal
bronchioles, the airways are no longer supported by a cartilage and are simply supported
by the airway wall and smooth muscle, as well as the matrix composed of alveoli.
As shown in Figure 1-2, the airway tree can be split into the conducting zone and the
respiratory zone. The conducting zone is comprised of the airways which do not participate
3

in gas exchange, whereas the respiratory zone is comprised of airways which are lined with
alveoli. Conducting zone airways hold approximately 150 millilitres of air, and are often
referred to as dead space as they do not participate in gas exchange. This is converse to the
respiratory and transition zone airways, which participate in gas exchange and can hold
approximately 2.5-3 litres at rest, depending on the size of the individual’s lungs.11
Within the conducting zone the airflow is driven by bulk flow and the inertia of the air.
Once through the conducting zone, the total cross-sectional area of the airways increases,
slowing the velocity of airflow. From this point onward, the air movement is largely due
to diffusion of the gas.

Figure 1-2: Idealized human airway generation diagram.
Adapted from Respiratory Physiology: The Essentials 10th edition.11

1.2.2

Parenchyma

The lung and airway system is designed to maximize the surface area available for gas to
diffuse into the blood. Small alveolar sacs comprise the terminal point of the airways,
where the wall is thin enough to allow oxygen to diffuse into the bloodstream. These wellformed, small alveolar sacs provide the lung with 50-100 m2 of surface area for gas
4

exchange. Figure 1-3 displays a diagram of the alveoli and bloodstream interaction, where
it can be seen that the alveoli takes a spherical shape to maximize the surface area. There
are approximately 500 million alveoli within the lung,12 with a dense capillary network
around the alveoli. The capillaries which participate in gas exchange are not much larger
than a single blood cell, and the alveolar-capillary membrane is extremely thin,
approximately 0.2-0.3 µm, allowing for fast diffusion of gases across the membrane.

Figure 1-3: Diagram of oxygen exchange into the bloodstream.
Diagram showing gas (blue circles) exchange into the bloodstream from the alveoli.

Pathophysiology of Chronic Obstructive Pulmonary
Disease
Lung disease can occur from an abnormality or dysfunction in any of the components
above, preventing optimal delivery of oxygen to the bloodstream. COPD is characterized
by persistent airflow limitation caused by a combination of parenchymal destruction
(emphysema) and airways disease (chronic bronchitis).3 COPD is progressive over time,
and is a result of exposure to exogenous irritants such as cigarette smoke,
environmental/occupational irritants or genetic conditions such as alpha-1 antitrypsin
deficiency.3
5

Figure 1-4: Diagram of pathophysiology of chronic obstructive pulmonary disease.
Healthy airway and obstructive lung disease panels are adapted from Hogg (2004),13
permission to reproduce provided in Appendix E. Healthy Alveoli and Emphysema are
adapted from Woods et al. (2006),14 permission to reproduce provided in Appendix E.

1.3.1

Emphysema

Emphysema is characterized by enlargement of the airspaces distal to the terminal
bronchioles, where gas exchange occurs. This enlargement is due to the destruction of
parenchymal tissue, where the effects can be observed in the lower right quadrant of Figure
1-4, compared to healthy alveoli in the lower left quadrant. The destruction of parenchyma
may be heterogeneous and to varying severities in different regions within the lung, which
give sub-classifications of emphysema including: centrilobular, panlobular and bullous
emphysema. Many patients have a combination of these sub-classifications, and in severe
emphysema it may be difficult to distinguish them.
Some of the earliest observations of emphysema stem from work in the 1950s from
Leopold and Gough. Their seminal work included observations on the inflammation,
calibre of bronchi and weakness within emphysematous spaces.15 Since then, there have
been extensive studies, moving from two-dimensional ex vivo measurements of
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emphysema, to three-dimensional ex vivo measurements of emphysema,16-18 and
eventually in vivo monitoring of emphysema using imaging as described in Section 1.5.
The understanding of COPD changed in the 1960s, when Dr. James Hogg et al. published
“The site and nature of airway obstruction in chronic obstructive lung disease”,
demonstrating the importance of the small airways.19 They observed that in a healthy
individual, the small airways contributes a small amount of the total airways resistance.
However, in patients with COPD it was observed this relationship was inverted and small
airways resistance was significantly increased. This increased resistance was present in
regions with and without emphysema, indicating small airway abnormalities may predate
the development of emphysema.

1.3.2

Chronic Bronchitis

Chronic bronchitis is characterized by sputum production and airflow obstruction for
greater than three months during two consecutive years.3 The causes of cough and airflow
obstruction are believed to be inflammation, mucus and damage to airways. Early
investigations of chronic bronchitis observed a relationship between mucous
hypersecretion and thickening of the bronchial mucus glands,20-23 as well as between
mucous hypersecretion and accelerated lung function decline.24 An example of airway
inflammation and mucus presence is shown in the upper right quadrant of Figure 1-4, where
mucus is observed in the airway lumen leading to a decreased cross-section for airflow.

Clinical Measures of Global Lung Function
“Pulmonary function tests provide objective, quantifiable measures of lung function. They
are used to evaluate and monitor diseases that affect heart and lung function” Crapo
1994.25
To diagnose and monitor COPD, clinicians primarily rely on pulmonary function tests
(PFT). These are simple breathing maneuvers that monitor flow rate, lung volumes and gas
exchange at the mouth to provide information about the function of the lungs. These tests
include spirometry, plethysmography and the diffusing capacity of the lung for carbon
monoxide (DLCO). Measurement values can be expressed as percent of the predicted value,
7

which is a function of the patient’s age, sex, height and ethnicity.26 The impact of
obstructive lung disease on patients can also be measured using quality-of-life
questionnaires and exercise capacity tests.
Of the breathing tests available, spirometry is currently the simplest and most widely used.
Spirometry can be performed using a handheld device, such as that shown in Figure 1-5A.27
The patient performs multiple tidal breaths, then is instructed to inhale fully, followed by
a forceful exhalation until they cannot exhale further. A representative lung volume curve
measured by the spirometer is displayed in Figure 1-5A. From this maneuver, the forced
expiratory volume in one second (FEV1) and the forced vital capacity (FVC) are measured.
The clinical diagnosis of COPD is based on the lung volumes measured with spirometry,
as shown in Table 1-1. A ratio of FEV1 to FVC less than 70 percent is the diagnostic cutoff for COPD according to the Global Initiative for Chronic Lung Disease (GOLD)
criteria.3 The severity of COPD is then graded based on FEV1, where a lower percent of
predicted is indicative of increased obstruction.
Table 1-1: Diagnostic cut-offs from the Global Initiative for Chronic Lung Disease
(GOLD).
The pulmonary function test cut-off for diagnosis of COPD is for FEV1/FVC<70%, the
severity grading is based on FEV1 percent predicted.
Pulmonary Function Test
If FEV1/FVC < 70%
GOLD Grade 1
FEV1 ≥ 80%pred
GOLD Grade 2
50%pred ≤ FEV1 < 80%pred
GOLD Grade 3
30%pred ≤ FEV1 < 50%pred
GOLD Grade 4
FEV1 < 30%pred
Plethysmography can be used to measure additional lung volumes, based on Boyle’s law.28
The patient is seated in a sealed chamber, as shown in Figure 1-5B, and performs a series
of breathing maneuvers, including tidal breathing, full inspiration and full expiration. An
exemplar lung volume curve is also displayed in Figure 1-5B. In the context of COPD, the
residual volume and functional residual capacity will often be increased due to gas trapping
from the collapse of airways.
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Figure 1-5: Spirometry and plethysmography devices and measurements.
A) Handheld spirometer and measurements of the forced expiratory volume in one second
and the forced vital capacity. B) Plethysmography box for lung volume measurements.
Further, the morphology of the alveoli can be probed using the DLCO.29 This test is
performed by inhaling a specific mixture of gas, containing a low concentration of carbon
monoxide (CO) (0.3%). The patient then holds their breath at total lung capacity for eight
seconds, during which the CO diffuses across the alveolar-capillary membrane and into the
blood. When the patient breaths out, the concentration of CO is measured and compared to
the initial concentration, from which the amount of CO that has diffused into the blood is
inferred. Patients with emphysema will have a decreased DLCO due to a reduction of
alveolar surface area for gas exchange, however a decreased DLCO may also be indicative
of a thickening of the alveolar-capillary membrane, among other abnormalities.
The impact that COPD has on the life of a patient is also an important measure. To quantify
this, patient quality of life is measured using the St. George’s Respiratory Questionnaire
(SGRQ).30 The SGRQ includes information from different aspects of disease effects,
9

including symptoms, activity and impacts on daily life. The scores from each component
of the questionnaire are then averaged to give a single SGRQ value. Further, exercise
capacity can be quantified using tests such as the six minute walk test.31, 32 The six-minute
walk test, as well as other exercise capacity measurements, have been shown to be
clinically important measures.33-35
Despite the ability to simply and cost-effectively monitor lung disease, the tests described
above do not provide sensitive quantitative or regional measurements of lung disease. In
healthy individuals, the small airways contribute only a small portion of the total lung
resistance, however, in COPD these small airways may be where the disease begins,19 and
therefore may not be detected by measuring lung volumes and capacities.

Imaging Pulmonary Structure and Function
“There may be considerable obstruction in the peripheral airways that would affect
ventilation distribution and gas exchange but would have little effect on function tests
designed to reveal obstruction. When total airway resistance is elevated to a clinically
detectable level by disease in the small airways, obstruction is much more severe than is
generally recognized.” Hogg et al. 1968.19
Contrary to clinical measures of lung function, pulmonary imaging provides the
opportunity to view regional abnormalities within the lung. As discussed in Section 1.2,
the structure and function of the lung are innately connected. Anatomical imaging
modalities provide the opportunity to visualize the structural abnormalities which in turn
may be consequential in determining the functional abnormalities, which can be measured
using functional imaging techniques.

1.5.1

Structural and Anatomical Imaging

First introduced in the late 1970s, x-ray computed tomography (CT) allows for
visualization of the structure within the lung, as shown within Figure 1-6. Thoracic CT can
be acquired under breath hold conditions, where a patient is instructed to inhale fully, or
by inhaling a set volume of gas from functional residual capacity. CT then provides an
attenuation map of the lung, where a density of -1000 Hounsfield units (HU) indicates the
10

presence of air, and as such, voxels with a density near -1000 HU indicate regions of tissue
destruction. Two methods are commonly used to quantify the severity of emphysema in a
patient, either a threshold method or percentile method. The threshold method quantifies
the percentage of the lung that has a density of less than the threshold. Commonly used
thresholds include -910 HU,36 -950 HU37 and -960 HU.38 The percentile method reports
the value of the percentile density from a histogram, often used values include the 5th
percentile and 15th percentile. The ability to visualize emphysema in vivo has allowed for
sensitive monitoring of disease progression, and has been shown to reduce the statistical
power needed to perform clinical trials of treatment in alpha-1 antitrypsin deficiency
compared to spirometry.39
More complex CT analyses have also been employed, including metrics which examine
the statistical properties of low attenuating (< -960 HU) clusters in CT images.40 The
cumulative size distribution of low attenuating clusters were shown to follow a power-law
relationship, and the power-law exponent was shown to be reduced in relation to a decrease
in DLCO.40

Figure 1-6: CT Imaging of healthy, mild COPD and severe COPD individuals.
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Healthy DLCO= 106%pred, FEV1/FVC= 72%, FEV1 = 80%pred; Mild COPD DLCO=87%pred,
FEV1/FVC=60%, FEV1=94%pred; Severe COPD DLCO=17%pred, FEV1/FVC=29%,
FEV1=28%pred. Yellow areas show regions of density less than -950 HU.
CT can also be used to visualize the airways and vasculature within the lung. Spatial
resolution in low-dose CT typically limits the segmentation of airways to ~7th generation
airways (~2 mm diameter). Despite these limitations, from airway segmentations,
important measurements can be made such as airway wall thickness, wall area and lumen
area. Airway measurements have led to observations including recent work showing
apparent loss of airways in severe emphysema,41 and the extent of this loss measured using
CT is an independent predictor of patient quality of life.42 CT measures have also been
shown to be risk factors for exacerbations, including the percentage of emphysema or
airway wall thickening which were both associated with COPD exacerbation frequency.43
Further, changes in pulmonary vasculature have been observed using CT perfusion
imaging, indicating there may be vasculature changes at early stages of COPD
development.44 Non-contrast enhanced CT has also been used to observe distal pruning of
small vessels in COPD, where a decreased ratio of small vessel blood volume to total blood
volume was shown.45, 46
More recently, high resolution structural images of the lung have been achieved using
magnetic resonance imaging (MRI). MRI of the lung presents a unique challenge because
there is a low density of tissue and many tissue/air interfaces. This means there is a small
magnitude of signal and a high amount of paramagnetic oxygen, which creates local field
inhomogeneities and increases the relaxation rate. To account for the increased relaxation
rate of the tissue within the lung, ultra-short echo time sequences have been developed.4750

These, and newer techniques such as zero echo time sequences, are advances towards

MR images achieving similar structural information as present within CT, with no radiation
dose to the patient.51

1.5.2

Functional Imaging

While structural information may indirectly inform upon the efficiency of the lung, with in
vivo imaging there is opportunity to image function within the lung.
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X-ray Computed Tomography
Contrast-enhanced CT utilizes inhaled xenon and dual energy techniques to image where
in the lung the xenon gas reaches to visualize ventilation. To accomplish this, dual-source
CT scanners are used for near-simultaneous acquisition of two separate energy spectra. The
separation between high and low energy spectra allows for differentiation between the
inhaled contrast gas, and the native materials to the lung, to generate gas distribution
images. Dual-energy CT has previously been applied to observe ventilation patterns in
patients with COPD.52, 53
In addition to dual-energy CT, it is possible to use air as a contrast agent by acquiring
images at multiple lung volumes, where you can attribute the change in density within an
anatomical location to the flux of air. Both four-dimensional CT (4D-CT) and multivolume CT have been used to create surrogate measures of ventilation by registering
multiple lung volumes acquired and quantifying the density change as air enters the lung.5459

Despite success of CT for functional imaging, the clinical adoption is limited due to the
increased radiation dose required for multiple, or extended length, scans. Additionally, the
necessity of additional scans or an exogenous contrast agent with specialized hardware
make these scans costly.

Hyperpolarized Gas Magnetic Resonance Imaging
Hyperpolarized gas MRI uses an exogenous gas, which is polarized to have an atomic spin.
When inhaled, the spatial distribution of the gas within the lungs can be imaged using
specialized receive coils within a magnetic resonance scanner. Due to the low spin density
available in the gas state, hyperpolarization is performed. This is done through optical
pumping, where angular momentum is given to an alkali metal (typically Rubidium)
through a circularly polarized laser at the resonance frequency of the metal (~794.6 nm for
Rubidium). The angular momentum is then transferred from the metal to the nuclei being
polarized (3He or

129

Xe) through collisions. The optical pumping technique can increase

the polarization of the gas up to five orders of magnitude greater than through a thermal
process.
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The field began in the 1990s, when inhaled 129Xe was first imaged within a mouse model.60
Since then, the use of hyperpolarized gas MRI has greatly expanded, and has seen the
adoption of hyperpolarized 3He, however, is currently undergoing a transition back to 129Xe
due to the increasing cost of 3He. Figure 1-7 displays the ventilation patterns measured
using hyperpolarized 3He across COPD disease severity. Cyan indicates the volumes
ventilated within a breath-hold, whereas dark regions are not ventilated. To quantify the
extent of ventilation abnormalities, the ventilation defect percent (VDP) is calculated as
the total volume of ventilation defects normalized to the thoracic cavity volume.61 The
Brownian motion of hyperpolarized gas under diffusion gradients has also been used to
probe microstructure of the lung using the apparent diffusion coefficient or
morphometry.14, 62-64 Work related to these measures is complimentary to the objective and
hypothesis of this thesis, and are presented in Appendix A-C.

Figure 1-7: 3He hyperpolarized gas MRI for healthy, mild COPD and severe COPD
individuals.
Examples of hyperpolarized 3He (cyan) overlaid on anatomical 1H (gray) MRI. The dark
regions within the lung are regions which are not filled within a breath hold, and are termed
ventilation defects. An increase in severity in COPD is related to an increase in ventilation
defects.
Both 3He and 129Xe hyperpolarized gas MRI have been shown to be safe and reproducible
measures.65-67 In COPD patients, 3He VDP is related to spirometry,68 symptoms and
exercise capacity,69 CT based measurements of emphysema and patient exacerbations.70, 71
Ventilation defects have also been shown to be spatially related to structural observations
of gas trapping and emphysema as measured using CT parametric response maps.72 Using
129

Xe has yielded similar observations, with many of the 3He studies being paired with
14

129

Xe, as well as independent studies where the VDP was again shown to be related to

spirometry.73
It is important to note that despite each ventilation imaging technique relating to patient
measures, they all vary slightly on the physiology they are probing. There are known
differences between 3He and

129

Xe,68, 74, 75 likely due to the density and viscosity of each

gas allowing for different flow dynamics (based on Reynolds Numbers) in different calibre
airways. Differences between CT-derived ventilation and hyperpolarized gas imaging have
recently been reported,76 where a portion of the difference is likely a difference due to
different breathing maneuvers. The majority of hyperpolarized gas imaging is based on
static breath-holds, whereas CT is based on volumes throughout the breathing cycle.

Texture Analysis in Medical Imaging
“Texture is an innate property of virtually all surfaces … It contains important
information about the structural arrangement of surfaces and their relationship to the
surrounding environment.” Haralick 1973.77
In medical imaging, texture analysis provides a quantitative method for describing patterns
within an image, which may relate to different underlying pathophysiological
determinants. Texture analysis has played a large role in the field of computer-aided
diagnosis, where biomedical images are mined for information reflecting underlying
pathophysiology which can then be used for the detection and diagnosis of disease.78 The
rapid growth of the application of texture analysis and machine learning in medicine is
evident in Figure 1-8, where an exponential increase in PubMed search results are
observed, compared to a near linear increase in CT and MRI.
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Figure 1-8: PubMed results for thesis keywords.
Displaying the number of results sorted by year, displaying an indirect observation of the
popularity of these methods.

1.6.1

Typical Work Flow

A typical workflow for texture analysis is outlined in Figure 1-9, where it includes image
acquisition, region of interest definition, feature extraction from the region of interest, and
feature analysis. The feature analysis can involve calculating which features are unique to
certain regions, or including features within a machine learning algorithm. Below, the
methods used for each of these steps are described, where segmentation and registration
can be used to define a region of interest, and feature selection and machine learning are
methods to analyze the extracted features.
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Figure 1-9: Typical workflow for texture analysis.
The typical workflow for texture analysis include image acquisition, region of interest
definition, feature extraction then feature analysis. ROI=region of interest.

Segmentation
Medical image segmentation is the task of partitioning an image into multiple regions,
based on a specified similarity characteristic. The simplest segmentation is done manually,
where an observer outlines the structure desired. However, this method can be quite time
intensive, and leads to high variability depending on the observer. Due to this, medical
imaging has moved to semi-automated or automated segmentations. Segmentation of the
lung cavity is a relatively easy task because there is a distinct density difference between
lung tissue and other tissue. However, it is complicated by the presence of vasculature,
diseased tissue and differentiating the trachea from lung tissue.
The simplest computer aided segmentation approach is based on thresholding the image.
Thresholding partitions the image into different regions based on a set, or algorithmically
determined, signal intensity.79,

80

Another approach to segmentation is region growing

techniques, which segments regions connected by intensity similarities. This can be
performed by manually, or automatically selecting a seed location, and growing the region
by iteratively adding neighboring pixels within a certain similarity criteria.81, 82 These
methods have been employed to segment proton MRI thoracic cavity images previously.61
More advanced methods including watershed,83 clustering,84,

85

and model based

techniques86 have also been employed. Many of these methods have been utilized to create
automated lung segmentation algorithms as an integral step in computer-aided diagnosis
pipelines.87-89
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More recently, deep learning has been applied to medical image segmentation, with the
wide adoption of convolutional neural network architectures such as U-Net.90 U-Net is a
neural network architecture which gained popularity after outperforming other
segmentation tasks in multiple Grand Challenges. The U-Net architecture has also been
extended to be compatible with volumetric segmentation, versus 2-dimensional
segmentation, in a network referred to as V-Net.91 Converse to the previously described
segmentation techniques, deep learning does not follow rule based segmentation, and
instead learns to identify features relevant to the specific segmentation task trained on
through backpropagation. One common limitation with deep learning for segmentation is
the necessity for large labeled datasets, which can be time consuming to curate or difficult
to attain. However, there are open source trained segmentation networks available on
repositories such as GitHub or NiftyNet92 which can be more simply applied to a specific
segmentation task without needing to train an entire network.

Registration
Registration is often required to determine the ground truth for texture analysis, whether
that be registering MRI to histology, conventional to contrast-enhanced images, or
structural to functional images. There are different registration techniques including rigid,
affine and deformable. These techniques enforce limits on how the images can be moved
or warped to match the other image. Rigid registration allows only translations and
rotations of the moving image, and affine registrations maps parallel lines across the
images being registered. Deformable registration cannot be represented using a
transformation matrix, and instead creates local vector displacement fields to map the
images to the same space. The technique you choose will depend on the registration task,
where a rigid or affine registration is often sufficient if the images being registered are of
the same anatomical space. However, for registration of inherently different images,
deformable registrations may be more successful.
A simple registration technique is landmark based registration, where a user places
landmarks at the same anatomical location on the two images to be registered, and a
deformation is calculated and applied to minimize the difference in the locations. This
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method has previously been developed for affine registration of hyperpolarized gas MRI
to anatomical proton MRI.61 More complex registration methods work to minimize a cost
function based on the similarity of the images being registered, or by matching segmented
surfaces. State-of-the-art registration algorithms used in medical imaging include the
demons registration93 and the modality independent neighbourhood descriptor (MIND)
registration.94

Feature Extraction
To describe the underlying patterns within the image, feature extraction is performed. The
simplest features can be extracted from the histogram of values within the region of
interest. These first-order features include the mean, median, mode, standard deviation,
skewness and more. In CT imaging, these relate to the density, and include quantitative CT
measures discussed in Section 1.5.1 including the relative area less than a threshold value,
or the histogram percentile.
Despite containing information on the voxel values within a region of interest, first-order
features do not contain any information regarding the spatial distribution of voxels. To
overcome this, frequently used approaches are based on second-order statistics which
quantifies the relationship between voxels. Two of the most commonly used second-order
statistic features include gray level co-occurrence matrix (GLCM)77 and run length matrix
(RLM)95 derived features.96 The GLCM is populated by recording the number of times
gray-level values appear within proximity to each other, where the column and row indices
represent the pixel value, and the value within each element is the number of times the
pixel values appear next to each other. Therefore, a GLCM with large values close to the
diagonal represents an image that does not have many sharp edges. The RLM is populated
by recording the number of runs within an image, where the row indices are the pixel value
and the column indices are the length of a run, and the element value is the number of runs.
Therefore, a RLM with most values in the first columns indicates an image which is very
heterogeneous in appearance.
Many further texture features may be calculated, including filter based methods, local
binary patterns, spherical harmonics, Markov models and wavelets. A comparison of the
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use cases and properties of each of these features are presented in a review of threedimensional texture features in medical imaging.96
To account for noise, and reduce the size of the matrices, values must be binned to create
both RLM and GLCM. If this is not performed, there would be virtually zero runs within
the RLM, as there would be a very small chance of the exact same value appearing. A
similar problem would be observed within the GLCM. The width of the bin will be a
determinant of how well the features describe the region of interest; if the bin width is too
small, the features will be noisy, whereas if it is too large you will not be sensitive to
differences which may be physiologically relevant. The bin width is therefore a parameter
that should be carefully chosen and is often experimentally determined to address what is
best for the specific task. To address these problems, filtering and smoothing of the image
may also be performed.
More recently, with the advances made possible from improvements in hardware and
software, deep neural networks have been widely adopted in medical image analysis. The
most popular method for deep learning, a subtype of machine learning, is using
convolutional neural networks (CNN). Conceptually, CNN are iteratively trained to learn
abstractions of images from low level (such as edges and corners), to high level (such as
shapes and concepts) features. These abstractions are learned and stored in filter banks,
which are specially tuned to the type of image the CNN was trained on. As discussed,
texture analysis aims to describe underlying patterns in an image, and in the same way,
filter banks from a CNN quantify patterns observed. The largest difference between the
methods is that texture analysis relies on hand crafted features, whereas deep learning
automatically learns features which are relevant to a task, and typically has much greater
capacity for abstraction. Further, the filter banks and features generated from a CNN do
not require the next two steps (feature selection and machine learning for classification),
as the last layer of a CNN generates class labels. However, a limitation to deep learning is
the requirement of a large amount of training data, and the computational complexity of
handling a large amount of data.
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Feature Selection
Feature selection aims to minimize the subset of features used from the original set of
extracted features, such that the generalizability of the model is maximized. There are many
factors that must be considered when choosing which features to use, including the size of
the dataset you have. It has been observed the error of a classifier decreases and then
increased as the number of features included increase.97 There have been different studies
into the optimal number of features to include, however the consensus is the number varies
largely depending on the task.98
Methods to perform feature selection include forward selection and backward selection. In
forward selection, features are iteratively added to the model based on the feature which
increases the performance metric the most, whereas backward selection starts with the
entire set of features and iteratively removes features which leaves the highest performing
model. Further methods include dimension reduction by using tools such as principle
component analysis or independent component analysis which aim to explain variance
within the data, however, the interpretability of the features can be complicated while using
these approaches. It is also important to select features which will be steady in different
circumstances; for example, it is undesirable to include features that are highly dependent
on user input, such as a segmentation. As such, a step can be included to select only features
which are steady through different observer segmentations. To do this, a metric such as the
intraclass correlation coefficient (ICC) may be used to compare the ranking of features
across different segmentations.

Machine Learning
Once features are chosen to represent an image, or region in an image, machine learning
can be used to determine how to combine the information from different features to
minimize a cost function. The simplest example of this is a linear regression, where you
want to minimize the sum of the squares of the distance from the line of best fit to each
data point. When you have more than one feature, this task becomes more complicated.
Machine learning approaches can generally be classified as supervised, or unsupervised
learning. Unsupervised approaches look for patterns within a feature set, creating clusters
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of features, without knowing an associated label for each cluster. Supervised approaches
look to separate the feature space based on a label associated with each data point. Popular
supervised machine learning algorithms used in medical imaging include logistic
regression, linear discriminants, support vector machines, decision trees and neural
networks.99
A logistic regression is used for classification problems by estimating the probabilities for
each class using a logistic function, also known as a sigmoid function, as the activation
function which maps your algorithm value to a probability between [0, 1]. To train a
logistic regression, the cross-entropy cost function is typically used. Similarly, a support
vector machine aims to find the hyperplane which separates two classes, while maximizing
the distance from the plane to each of the closest points, or support vectors. In cases which
the data are not linearly separable, a non-linear kernel can be used to map the data to a
linear space, as well as an application of a soft-margin. To train a support vector machine,
the cost function rewards being at least one unit away from zero in the cost space, which
aims to minimize the data points which lay within a margin to the separating hyperplane.
Due to the inclusion of distance to points in space in the cost function, standardization or
normalization of the features is an important pre-processing step. Standardization is
performed by subtracting the feature mean and dividing by the standard deviation, while
normalization is performed to rescale all data to the range of [0, 1]. Other classifiers include
decision trees which learn decision rules for each feature to classify based on features,
nearest neighbor, which classifies based on how similar a data point is to previously
observed data, and a neural networks train to learn the combination of features and weights
to predict the class. Each of these have different underlying algorithms, but all aim to
minimize a cost function, such that when presented with a new data point they can predict
the associated label as accurately as possible.

1.6.2

Challenges and Limitations

One of the largest challenges in texture analysis for medical imaging is deciding which of
the methods discussed in Section 1.6.1 to implement. As is evident, there are a high number
of combinations and permutations of texture features, feature selection and machine
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learning methods. There is no standard combination that is the “best” to employ due to the
fact that each medical image analysis problem is unique. Therefore, one of the most
important parts of any texture analysis or machine learning project is managing the dataset
to be able to validate and eventually test your specific method. If done correctly, a training,
validation and testing split allows for confidence in the performance of the model created.
For example, many machine learning methods may be used to generate a model from the
training set, then be applied to the validation set. The highest performing model as
determined on the validation set, can then be applied to the testing set to report the overall
performance of the model generated. This ensures a decision on the best machine learning
algorithm was determined experimentally, greatly reducing the likelihood the final model
has been over fit to the data.
Another important challenge is the generalizability of the models created using texture
analysis. To obtain the best results, homogenous collection of the data is desired, where
the same imaging protocol is employed across all subjects. However, to translate the model,
differences across sites must be understood and considered. It is known the protocol
parameters (slice thickness, voxel spacing), reconstruction kernel, and scanner vendor all
effect texture features.100-102 The robustness of features across different scanners can be
studied, including measuring feature robustness as a metric within feature selection. There
is also recent work being done to standardize features across scanners.103

1.6.3

Applications in Lung Imaging

Computer-aided diagnosis has been around since before the digitization of medical images,
where a pattern recognition approach was introduced to preprocess images, extract features
and perform classification.104 Within lung imaging, a large number of studies applied
feature analysis to chest x-ray images in a series of studies on “Image feature analysis and
computer-aided diagnosis in digital radiography” from Dr. MacMahon and colleagues.105112

More recently, texture analysis has been applied to CT images for the detection and
classification of pulmonary nodules,113-116 which is also referred to as radiomics. Here, it
has been observed that in addition to analyzing the tumour volume, it is beneficial to
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analyze the parenchymal tissue.117, 118 Texture analysis has also been applied to create
automated lung disease classification, including fibrosis,119 pneumonia120 and obstructive
lung disease such as emphysema.121-125 All of these studies employed slightly different
approaches to texture analysis, with different ground truths, however demonstrate the
ability of texture analysis to capture important information within thoracic CT images.

Thesis Hypotheses and Objectives
Hyperpolarized gas MRI has been used to provide unique functional information in patients
with COPD, and has been shown to relate to important patient outcomes and have the
potential to guide treatment. Unfortunately, this specialized information is currently limited
to a small number of research centres due to the high cost of hyperpolarization equipment
and gas. This is converse to widely available thoracic CT, which provides high-resolution
anatomical images. The overarching objective of this thesis is to use texture analysis and
machine learning to generate the functional information contained within hyperpolarized
gas MRI, from a single-volume, non-contrast enhanced thoracic CT. To do this,
hyperpolarized gas MRI were registered to thoracic CT to provide the ground truth training
label. First and second order features were then extracted from each volume of interest,
which were used to create a machine learning model. We hypothesized that the structural
information contained within a single-volume breath hold CT can inform on regional lung
function. This hypothesis has a basis in previous observations using thoracic CT, such as
the airway and vasculature changes associated with COPD, and the previously reported
spatial overlap between CT emphysema measures and ventilation defects. The objective
of Chapter 2 was to development a texture analysis pipeline, and apply the pipeline is a
small cohort as proof-of-concept.
The objectives in Chapter 3, were to apply improve upon the methods developed in Chapter
2, and apply this pipeline in a larger set of patients. To do this texture features, the volume
of interest size, and the sampling method were optimized within the training set of this
cohort. The optimal performing model was then applied in the testing set of 27 participants.
We hypothesized that the model predicted ventilation maps would qualitatively and
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quantitatively relate to ground truth MRI ventilation maps, as well as important clinical
measures.
In Chapter 4, I provide a summary of the impact and conclusions from Chapter 2 and 3, as
well as discuss limitations and future steps to build upon the research presented in this
thesis.
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CHAPTER 2

2

TEXTURE ANALYSIS OF THORACIC CT TO
PREDICT HYPERPOLARIZED GAS MRI LUNG
FUNCTION

To develop a pipeline for predicting hyperpolarized gas MRI ventilation based on texture
analysis of thoracic CT, a small cohort of COPD patients were evaluated. Predicted
ventilation maps were compared to ground truth hyperpolarized gas MRI ventilation.
The contents of this chapter were accepted as conference proceedings in SPIE Medical
Imaging and permission to reproduce the article was granted by SPIE: A Westcott, D.P.I
Capaldi, D.G McCormack, A Fenster and G Parraga. SPIE Medical Imaging 2019.

Introduction
Pulmonary imaging provides a unique opportunity to guide treatment and monitor disease
progression in patients with chronic obstructive pulmonary disease (COPD). Currently,
such regional information can be gleaned using contrast-enhanced X-ray computed
tomography (CT), typically by using inhaled xenon gas with dual energy CT, at two
different inspiration volumes, or free breathing volumetric CT image acquisition (4DCT)
that employ advanced registration and analysis techniques.1
Recently, hyperpolarized gas MRI has been developed and exploited in COPD patients
because it does not employ ionizing radiation, which augers well for serial imaging studies.
Hyperpolarized 3He and 129Xe MRI have been shown to be reproducible and measurements
or biomarkers derived using both approaches are sensitive to changes over short periods of
time,2, 3 as well as having the potential to guide treatment such as bronchoscopic lung
volume reduction.4 MRI ventilation information and ventilation defects can be quantified
using the ventilation defect percent (VDP), which quantifies the volume of the lung not
ventilated or poorly ventilated during a breath-hold scan of 8-12s.5 Although the functional
information hyperpolarized gas MRI provides is unique, the method is limited to research
centres of excellence, which limits its clinical translation and use in multi-centre clinical
cohort studies and clinical trials. Moreover, CT and thoracic CT protocols are universally
available and this has facilitated the acquisition of CT in large cohort studies such as
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COPDGene,6 ECLIPSE,7 SPIROMICS,8 and CANCold,9 which have together resulted in
tens of thousands of thoracic CT images acquired in COPD patients for analysis.10
We postulated that by combining the use of texture analysis and machine learning, the
ventilation information provided by hyperpolarized gas MRI could be transferred directly
to thoracic CT acquired at the same breath-hold volume. The acquisition of a large number
of MRI-CT pairs in the cohort study TinCAN,11 provides an opportunity to train and test a
machine learning approach to distinguishing ventilated from non-ventilated regions based
on CT.
Therefore, the aim of this research was to develop and evaluate novel texture analysis tools
to be used on CT images, using hyperpolarized gas MRI to determine the ground truth
label. We hypothesized that a model utilizing first and second order features can be
developed to classify CT regions as ventilated or non-ventilated based on hyperpolarized
gas MRI ventilation maps.

Materials and Methods
2.2.1

Study Subjects and Image Acquisition

Subjects with a confirmed diagnosis of COPD provided informed written consent to a study
protocol approved by a local research ethics board and Health Canada.11 These participants
have been extensively investigated in a longitudinal cohort study.12 1H and 3He MRI were
performed on a 3T whole-body system (MR750 Discovery, General Electric Health Care
[GEHC], Milwaukee, WI) as previously described.11

Thoracic CT images were also

acquired as previously described11 on a 64-slice Lightspeed VCT scanner (GEHC,
Milwaukee, WI) (64 × 0.625 mm, 120 kVp, 100 effective mA, rotation time = 500 ms, and
pitch = 1.0). For CT, 1H and 3He imaging the subject was scanned in the supine position
in breath-hold after inhalation of a 1-L bag from functional residual capacity to match lung
volumes between scans. 10 subjects displaying CT evidence of emphysema (CT RA950 >9),
and with a high ventilation defect percent (VDP>12%) were randomly selected, and
randomly split into a training (n=7) and test (n=3) set.
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2.2.2

Proposed Pipeline

Figure 1 displays the pipeline developed to classify CT volumes-of-interest (VOI), based
on breath-hold CT images, feature extraction, a trained feature classifier and
hyperpolarized gas MRI as ground truth.

Figure 2-1: Proposed texture analysis pipeline for classifying CT volumes of interest
(VOIs) into ventilation defects or ventilated.

2.2.3

Hyperpolarized MRI to Thoracic CT Registration

CT images were concatenated to 15mm thick slices to match the MRI dimensions. MRI
data were resampled and cropped to result in 1.25x0.7mm pixels - the original CT x-y plane
dimensions. 1H MRI thoracic cavity images were registered to the CT using an affine
landmark based registration, described previously for 1H to 3He registration (MATLAB
R2018a; MathWorks, Natick, MA).5 The calculated registration transformation was
applied to the MR ventilation cluster maps, which were generated by registering the 1H to
3

He and clustering using k-means clustering as previously described.5 CT images were

segmented using Pulmonary Workstation 2.0 (VIDA Diagnostics Inc., Coralville, IA).
CT and MR VOI were defined by applying a 3-dimensional grid, with isotropic dimensions
of 15x15x15mm, on both the segmented CT and MR ventilation map. The MR ventilation
map was labeled as background, ventilated and non-ventilated, with the label of a VOI
being the mode, or most common, value. The grid was then shifted 7.5mm horizontally
and 7.5mm vertically, to generate additional training samples, such that each voxel belongs
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to three separate VOI. This technique was further utilized when predicting the final label
in the test set, as the mean was used between three overlapping 15x15x15 VOI, which then
defined a 7.5x7.5x15mm region. Figure 2 shows the MR-CT registration and VOI
extraction process.

Figure 2-2: MRI to CT registration pipeline.
Displaying the 3-dimensional grid used to define CT VOIs and corresponding MR based
ventilation label.

2.2.4

Thoracic CT Feature Extraction

First and second order features were extracted using a custom-built texture analysis
software as described below (MATLAB R2018a; MathWorks, Natick, Mass).
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First Order Statistics
The first order features used were mean CT density, standard deviation density, skewness,
kurtosis, 95th percentile density, 15th percentile density (HU15), relative area of the lung
less than -950 HU (RA950), relative area less than -910 HU (RA910) and relative area less
than -856 HU (RA856).

Gray-level Co-occurrence Matrix
The gray level co-occurrence (GLCM) matrix is a measure of the number of times voxels
of the same value appear next to each other.13 The matrix was populated by classifying
voxels based on Hounsfield Units (HU) into 20 bins from 0 to -1000 HU, each with a 50
HU size range. Using methodology previously described,13 features were calculated as
shown in the right side of Table 1, for the 13 unique 3-dimensional directions.

Cluster Volume Matrix
The run-length matrix is commonly used as a method to extract features from 2dimensional images.14 However, calculating run lengths in 3-dimensions becomes
computationally intensive, and does not take into account regions that are fully, but not
linearly, connected. Further, in COPD, cluster of low attenuating regions are clinically
relevant.15 Therefore, here we employed a combination of the run-length matrix with CT
cluster analysis by creating the cluster volume matrix (CVM), for novel CT texture
features. This is essentially a 3-dimensional extension of the run length matrix, where
𝑝(𝑖, 𝑗) is the number of clusters, and 𝑖 is still the gray-level, but 𝑗 is the 3-dimensional
cluster size of the same gray-level. The features calculated from the CVM are the same as
those calculated from a run-length matrix, as shown in the left column of Table 1. The
matrix was populated by classifying into 40 HU wide groups between -500 and -1000,
where all voxels greater than -500 were collapsed into a single group.
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Table 2-1: Equations to calculate features from a gray-level run length matrix and to
calculate features from a gray-level co-occurrence matrix.
𝑝(𝑖, 𝑗) is an element of the gray-level run length matrix, where 𝑖 corresponds to the image
intensity, and 𝑗 corresponds to the number of homogenous runs of length 𝑗 and 𝑛𝑟 is the
total number of runs. 𝑔(𝑖, 𝑗) is an element of the co-occurrence matrix. 𝜇 = ∑𝑖,𝑗 𝑖 ∗ 𝑔(𝑖, 𝑗)
is the mean, 𝜎 = ∑𝑖,𝑗 𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝜇)2 is the variance.
CVM Feature
Short Run Emphasis
(SRE)

Equation
1
𝑝(𝑖, 𝑗)
∑
2
𝑛𝑟
𝑖,𝑗 𝑗

GLCM Feature

Long Run Emphasis
(LRE)

1
∑ 𝑝(𝑖, 𝑗) ∗ 𝑗 2
𝑛𝑟
𝑖,𝑗

Gray-level
Nonuniformity (GLNU)

1
∑ (∑ 𝑝(𝑖, 𝑗))
𝑛𝑟
𝑖
𝑗
2
1
∑ (∑ 𝑝(𝑖, 𝑗))
𝑛𝑟
𝑗
𝑖
𝑛𝑟
∑𝑖,𝑗 𝑗 ∗ 𝑝(𝑖, 𝑗)
1
𝑝(𝑖, 𝑗)
∑
2
𝑛𝑟
𝑖,𝑗 𝑖
1
∑ 𝑝(𝑖, 𝑗) ∗ 𝑖 2
𝑛𝑟
𝑖,𝑗

Run
length
Nonuniformity (RLNU)
Run Percentage (RP)
Low gray-level run
emphasis (LGRE)
High gray-level run
emphasis (HGRE)
Short run low graylevel
emphasis
(SRLGE)
Short run high graylevel
emphasis
(SRHGE)
Long run low graylevel
emphasis
(LRLGE)
Long run high-gray
level
emphasis
(LRHGE)

2.2.5

Equation

Energy

∑ 𝑔(𝑖, 𝑗)2

Entropy

∑𝑖,𝑗 −log(𝑔(𝑖, 𝑗)) ∗ 𝑔(𝑖, 𝑗)), if 𝑔(𝑖, 𝑗) ≅
0
0 if 𝑔(𝑖, 𝑗) = 0

Contrast

∑ 𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝑗)2

2

Homogeneity
Correlation

𝑖,𝑗

𝑖,𝑗

𝑔(𝑖, 𝑗)
2
𝑖,𝑗 1 + (𝑖 − 𝑗)
𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝜇) ∗ (𝑗 − 𝜇)
∑
𝜎2
𝑖,𝑗
∑

1
𝑝(𝑖, 𝑗)
∑ 2 2
𝑛𝑟
𝑖,𝑗 𝑖 ∗ 𝑗
1
𝑖2
∑ 𝑝(𝑖, 𝑗) ∗ 2
𝑛𝑟
𝑗
𝑖,𝑗
1
𝑗2
∑ 𝑝(𝑖, 𝑗) ∗ 2
𝑛𝑟
𝑖
𝑖,𝑗
1
∑ 𝑝(𝑖, 𝑗) ∗ 𝑗 2
𝑛𝑟
𝑖,𝑗
∗ 𝑖2

Training a Classification Model

In total there were 85 features extracted to describe each CT volume, which were then used
as the input to the classifier model. To train the model we used an even number of ventilated
and non-ventilated regions from each subject, randomly selecting ventilated regions to
match the number of non-ventilated regions. To obtain a training accuracy, which could
provide an adequate estimate of the entire dataset, the training set was trained in five
iterations with each iteration being trained on 80% and tested on 20% of the training data,
where the testing 20% is unique for each iteration. This 5-fold cross-validation training
was performed using a logistic regression, linear support vector machine (SVM) and a
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quadratic SVM. To compare models, the mean accuracy of the 5-fold cross-validation was
calculated and a receiver-operator-characteristic (ROC) curve was generated. From the
ROC curve, the area under the curve (AUC) was also calculated as a global summary of
the classifier performance.

Results
2.3.1

Study Subjects

Demographics, pulmonary function tests, CT and MR imaging measurements for ten
subjects with COPD are provided in Table 2.
Table 2-2: COPD Subject demographics, pulmonary function tests, CT and MR imaging
measurements
Training (n=7)
Test (n=3)
Age years
72 (6)
81 (5)
Sex (M/F)
3/4
3/0
Pack Years
60 (40)
50 (20)
FEV1 %pred
33 (7)
42 (13)
FEV1/FVC
36 (8)
36 (7)
DLCO %pred
30 (9)
29 (8)
RA950 %
21 (9)
21 (7)
VDP %
27 (7)
28 (2)
FEV1=forced expiratory volume in 1 second; FEV1/FVC=FEV1 ratio with
forced vital capacity; %pred=percent predicted; DLCO=diffusing capacity for
carbon monoxide; RA950=relative area of CT histogram <-950 HU.
VDP=ventilation defect percent.

2.3.2

Model Results

Three different classification algorithms were trained including logistic regression, linear
SVM and quadratic SVM using ~20,000 VOI, with an even proportion of ventilated and
ventilation defect VOI. The results for each classification method are displayed in Table 3.
Quadratic SVM performed best in both accuracy and area-under-curve, so it was applied
to the test set of patients. Table 3 shows accuracy and AUC and Figure 3 shows the
confusion matrix and receiver-operator-characteristic curve for the test subjects.
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Table 2-3: Results for training and test set of patients. Only the best performing model was
applied to the test set.

Number sub-regions
# ventilation defect
# well ventilated
Logistic Regression accuracy
Logistic Regression AUC
Linear SVM accuracy
Linear SVM AUC
Quadratic SVM accuracy
Quadratic SVM AUC

Training (n=7)
20718
10359
10359
67.3
0.74
67.3
0.73
70.9
0.78

Test (n=3)
17358
12783
4575
66.2
0.72

Figure 2-3: Confusion matrix and receiver-operator-characteristics (ROC) curve for the
test set of subjects.
The output of the model pipeline for a single test subject is shown in Figure 4 as a model
score map and the binary map with spatial agreement between the model-predicted
ventilation map and the ground truth 3He ventilation map shown with yellow arrows.
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Figure 2-4: CT, Model predicted score, model binary prediction and 3He cluster map for a
test subject showing representative centre and anterior slices.

2.3.3

Comparison to Conventional CT Measures

Spatial correlation between 3He ventilation defects and quantitative CT measures of
emphysema were previously discovered and described using the TINCan cohort study. 16
To explore the predictive value of quantitative CT measures, and the additional value of
texture features, we trained a logistic regression, linear SVM and quadratic SVM on the
same patient dataset, using only RA950 and HU15. The highest scoring model in the training
set using only these two measurements and logistic regression resulted in 61% accuracy
and an AUC of 0.66. This trained model was applied to the test set, with accuracy of 66%
with an AUC of 0.63. Figure 5 shows the output of the logistic regression trained using
only RA950 and HU15 next to the full model which showed qualitatively better prediction
of ground truth.
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Figure 2-5: “Conventional” versus Full Feature Models
The output of the logistic regression trained using only RA950 and HU15 (“Conventional”
Features), the output from the quadratic SVM model trained using the full set of features
(Full Features), the CT showing region of low attenuation (RA950), and the ground truth
3
He ventilation images.

New or Breakthrough Work to be Presented
We developed a pipeline to generate a new way to simulate 3He MRI ventilation defect
maps from a single-volume breath-hold CT and applied this in a proof-of-concept
demonstration in a small cohort of patients with COPD. In a small training and test dataset
of 10 COPD patients, this proposed approach yielded increased prediction success as
compared to emphysema CT biomarkers alone. To our knowledge, this is the first
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demonstration of texture analysis and machine learning to predict ventilation abnormalities
using single-volume thoracic CT.

Discussion and Conclusion
In this proof-of-concept demonstration, we developed a pipeline to co-register
hyperpolarized gas MRI and thoracic CT and extract features from CT ROI to create a
classification model and predict ventilated or non-ventilated. The prediction of lung
ventilation functional information from thoracic CT was recently described using multivolume CT and directly compared with hyperpolarized gas MRI.17 Our approach is based
on a single clinical CT in a small group of COPD patients and serves as validation for
future developments. Future work will be done to extend this method to include a larger
and more heterogeneous cohort of patients, which we hypothesize will increase both the
performance and generalizability of the model.
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CHAPTER 3
3

CHRONIC OBSTRUCTIVE PULMONARY DISEASE:
THORACIC CT TEXTURE ANALYSIS AND MACHINE
LEARNING
TO
PREDICT
PULMONARY
VENTILATION

Building on Chapter 2 where the pipeline for texture analysis was developed, we apply it
here in a relatively large cohort (n=95). Here we optimize the free parameters and build
a texture model to predict ventilation based on widely available thoracic CT images.
The contents of this chapter were submitted to Radiology: A Westcott, D.P.I Capaldi, D.G
McCormack, A Ward, A Fenster and G Parraga. Chronic Obstructive Pulmonary Disease:
Thoracic CT Texture Analysis and Machine Learning to Predict Pulmonary Ventilation.
Radiology (Submitted February 26, 2019).

Introduction
In patients with chronic obstructive pulmonary disease (COPD), structural remodeling of
the airways, airway inflammation/obliteration and parenchyma destruction commonly
result from chronic inhalation of combustibles including tobacco cigarettes and biomass
fuels.1 Pulmonary x-ray computed tomography (CT) is now widely used to visualize and
quantify COPD lung structural abnormalities and these measurements have been exploited
in large cohort studies including COPDGene,2 ECLIPSE,3 SPIROMICS,4 and CANCold,5
which have resulted in tens of thousands of thoracic CT images acquired in COPD
patients.6

While all of these studies have focused on anatomical measurements,

complementary functional information may also be gleaned using inhaled xenon gas and
dual-energy CT, or multi-volume CT acquisition through the breathing cycle in
combination with advanced registration and analysis techniques.7
Hyperpolarized

3

He and

129

Xe magnetic resonance imaging (MRI) pulmonary

measurements also provide high spatial and temporal resolution lung ventilation
heterogeneity and microstructural information in COPD patients.8, 9 Hyperpolarized gas
MRI measurements in COPD patients are reproducible over short periods of time,10
sensitive to therapy11 and to the lung changes that accompany exacerbations.12
particular, 3He and

129

In

Xe MRI ventilation heterogeneity, quantified as MRI ventilation
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defect percent (VDP),13 is predictive of COPD exacerbations,14 and longitudinal changes
in quality of life and exercise capacity.15 In spite of these unique advantages,
hyperpolarized gas MRI has been limited to specialized research centres and has not been
used in multi-centre cohort COPD studies and clinical trials, largely due to the high cost of
the hyperpolarized gas and specialized equipment. Unfortunately, the unique functional
information provided by hyperpolarized gas MRI has not been made as widely available
as CT, for clinical evaluations of COPD patients. With the recent successful utilization of
texture analysis and machine learning in medical imaging, we postulated it would be
possible to identify the necessary and sufficient features in CT images to generate lung
ventilation heterogeneity maps which would make this important lung functional
information more widely available.
The TINCan cohort study16 prospectively acquired volume-matched CT and MRI in a
relatively large group of COPD patients and provides a unique opportunity to train and test
a machine learning approach to generate pulmonary ventilation maps based on singlevolume, non-contrast CT. We hypothesized that ventilation maps could be generated based
on texture features and machine learning of CT images, and that such maps would
significantly correlate spatially with hyperpolarized 3He MRI ventilation defect percent
(VDP) acquired experimentally in COPD patients. Such pulmonary ventilation predictions
based on nearly universally available, conventional CT, may increase clinical access to
valuable functional lung information beyond sites with hyperpolarized gas MRI. Therefore,
the purpose of this study was to develop, train and test a pulmonary CT texture analysis
and machine learning pipeline to predict 3He MRI ventilation heterogeneity maps acquired
in the same COPD patients.

Materials and Methods
3.2.1

Study Design and Pulmonary Tests

Participants provided informed written consent to a longitudinal cohort study,17 approved
by a local research ethics board in compliance with the Health Insurance Portability and
Accountability Act (NCT=NCT02723474, Institutional Review Board #00000940).16 Data
were prospectively acquired from January 2010 to February 2017. Spirometry
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measurements were acquired according to the American Thoracic Society guidelines18
using a whole-body system (MedGraphics Corporation, St Paul, MN).

Body

plethysmography was performed for the measurement of lung volumes and diffusing
capacity of the lung for carbon monoxide (DLCO) was measured using the attached gas
analyzer. The St. George Respiratory Questionnaire (SGRQ)19 was employed as a measure
of quality of life.
Figure 3-1 shows the image processing pipeline we developed to generate ventilation maps
based on thoracic CT, as well as the consort diagram. Participants were excluded if they
did not have COPD, or if the CT acquisition parameters were prospectively altered to
include a modified inspiration-expiration protocol/scheme. One patient dataset was used to
perform texture parameter optimization and the remaining patient datasets were
randomized to a training set, for tuning model hyperparameters, and a testing set.

Figure 3-1: Schematic for Analysis.
A) Proposed texture analysis pipeline for generating predicted ventilation maps from
thoracic CT. B) Consort diagram showing the participants that competed a visit, those
excluded in this study due to not having COPD and those who had CT acquired with
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different voxel spacing. For the training set, participants were randomly divided into five
groups. Training was performed during five iterations, where for each iteration the model
was trained on four groups (gray rectangle), and validated on one group (blue rectangle).

3.2.2

Image Acquisition

Conventional proton (1H) and 3He MRI were performed on a whole-body 3T system
(MR750 Discovery, General Electric Health Care [GEHC], Milwaukee, WI) with
broadband imaging capabilities as previously described.8 1H MRI was performed using a
fast spoiled gradient-recalled-echo sequence, with acquisition parameters as previously
described.8

3

He MRI employed a whole-body gradient set with maximum gradient

amplitude of 50 mT/m and a single-channel, rigid elliptical transmit-receive chest coil
(RAPID Biomedical GmbH, Wuerzburg, Germany). The basis frequency of the coil was
97.3 MHz and excitation power was 3 kW using an AMT 3T90 RF power amplifier
(GEHC).

3

He gas was polarized to 30–40% polarization using a spin-exchange optical

polarizer (Polarean Inc, Durham, NC). Thoracic CT was acquired on a 64-slice Lightspeed
VCT scanner (GEHC, Milwaukee, WI) (64 × 0.625 mm, 120 kVp, 100 effective mA, tube
rotation time = 500 ms, and pitch = 1.0). CT images were reconstructed using a slice
thickness of 1.25 mm with a standard convolution kernel. The total effective dose to the
participant was 1.8 mSv according to manufacturer settings and Imaging Performance
Assessment of CT patient dosimetry calculator based on software from the Health
Protection Agency of the United Kingdom (NRPB-SR250). The dimensions in the coronal
plane for MRI were 3.1x3.1x15mm3 and in the CT were 1.25x0.7x0.7mm3.

3.2.3

Image co-Registration

Figure 3-2 shows the MRI-CT registration and volume-of-interest (VOI) extraction
approach. MRI 1H and 3He images were registered using landmark registration, and kmeans clustering was used to generate ventilation cluster maps, as previously described.13
MRI data were resampled to 1.25x0.7mm voxels to match the original CT coronal plane
dimensions and cropped to match the CT field-of-view. CT images were segmented using
Pulmonary Workstation 2.0 (VIDA Diagnostics Inc., Coralville, IA), then were
concatenated to 15mm thick slices in the coronal plane to match the MRI dimensions. The
segmented 1H MRI thoracic cavity masks were registered to the CT using a deformable
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registration, the modality independent neighborhood descriptor (MIND) registration.20 The
resultant registration transformation was applied to MRI ventilation cluster maps. Coregistration was evaluated using the Dice similarity coefficient (DSC).

Figure 3-2: MRI to CT registration pipeline.
A 3-dimensional grid was used to define CT volume of interest (VOI) and the
corresponding MRI based ventilation label where L is the length of the VOI in the coronal
plane which is varied to determine the optimal VOI dimensions. MIND=modality
independent neighborhood descriptor.

CT and MRI VOI were defined by applying a 3-dimensional grid, with dimensions of
LxLx15mm3, to the segmented CT and MRI ventilation map, where L was the VOI size in
the coronal plane, which was optimized within the training set. The MRI ventilation map
was labeled as background, ventilated and non-ventilated, with the label of each VOI being
the mode, or most common, value. The grid was then shifted L/2mm horizontally and
L/2mm vertically, to generate additional training samples, such that each voxel belonged
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to three separate VOIs. This technique was further utilized when predicting the final label
in the test set, as the mean score of three overlapping LxLx15mm3 VOIs was used, which
then defined unique predictions for L/2x L/2x15mm3 regions.

3.2.4

Thoracic CT Feature Extraction

First and second order features were extracted using a custom-built texture analysis
software using MATLAB (MATLAB R2018a; MathWorks, Natick, Mass). A parameter
search was performed to determine the texture parameters (GLCM bin width, CVM bin
width and CVM bin range) using one patient dataset, which was then removed for the
remainder of the analysis. The results from this parameter search is provided in Figure 3-3.
Exemplar feature maps using these optimized parameters are shown in Figure 3-4. In total
there were 87 unique features calculated per VOI, (i.e. global features). To provide the
model more context in terms of COPD severity, each VOI feature was also divided by the
average value of the feature within the same patient, and this generated an additional 87
features (i.e. ratio features), for a total of 174 features per VOI.

Figure 3-3: Texture parameter search.
Performed using single individual with VDP=25%. The set of parameters chosen were
those which had the greatest validation accuracy with stable accuracy values surrounding
it, as shown as CVM Width=40, CVM Cut-off=-300 HU, GLCM Bins=45.
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First order features that were generated included mean CT density, standard deviation
density, skewness, kurtosis, 2nd moment, 3rd moment, 95th percentile density, 15th percentile
density (HU15), relative area of the lung <-950 HU (RA950), <-910 HU (RA910) and <-856
HU (RA856).

Figure 3-4: Hyperpolarized MRI ventilation, thoracic CT image and feature maps.
Feature maps were calculated using VOI dimensions of 15x15x15mm3. HU=Hounsfield
Units; 15th percentile=the 15th percentile of CT density histogram; GLCM=gray level cooccurrence matrix; CVM=cluster volume matrix; GLN=gray level non-uniformity.
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The gray level co-occurrence (GLCM) matrix21 was populated by binning voxels based on
Hounsfield Units (HU) into 45 bins from 0 to -1000 HU, where 45 bins was the result from
the parameter search in the one patient removed. As previously described,21 features were
calculated as shown in the right side of Table 3-1 for the 13 unique 3-dimensional
directions.
Table 3-1: Equations used to calculate features.
𝑝(𝑖, 𝑗) is an element of the gray-level run length matrix, where 𝑖 corresponds to the image
intensity, and 𝑗 corresponds to the number of homogenous runs of length 𝑗 and 𝑛𝑟 is the
total number of runs. 𝑔(𝑖, 𝑗) is an element of the co-occurrence matrix. 𝜇 = ∑𝑖,𝑗 𝑖 ∗ 𝑔(𝑖, 𝑗)
is the mean, 𝜎 = ∑𝑖,𝑗 𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝜇)2 is the variance.
CVM Feature
Short Run
(SRE)
Long Run
(LRE)

Equation
Emphasis
Emphasis

Gray-level
uniformity (GLN)

Non-

Run
length
uniformity (RLN)

Non-

Run Percentage (RP)
Low
gray-level
run
emphasis (LGRE)
High
gray-level
run
emphasis (HGRE)
Short run low gray-level
emphasis (SRLGE)
Short run high gray-level
emphasis (SRHGE)
Long run low gray-level
emphasis (LRLGE)
Long run high-gray level
emphasis (LRHGE)

1
𝑝(𝑖, 𝑗)
∑
2
𝑛𝑟
𝑖,𝑗 𝑗
1
∑ 𝑝(𝑖, 𝑗) ∗ 𝑗 2
𝑛𝑟
𝑖,𝑗

GLCM
Feature

Equation

Energy

∑ 𝑔(𝑖, 𝑗)2

Entropy

∑𝑖,𝑗 −log(𝑔(𝑖, 𝑗)) ∗ 𝑔(𝑖, 𝑗)), if
𝑔(𝑖, 𝑗) ≅ 0
0 if 𝑔(𝑖, 𝑗) = 0

Contrast

∑ 𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝑗)2

2

1
∑ (∑ 𝑝(𝑖, 𝑗))
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𝑖
𝑗
2
1
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2
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𝑖,𝑗
1
𝑝(𝑖, 𝑗)
∑ 2 2
𝑛𝑟
𝑖
∗𝑗
𝑖,𝑗
1
𝑖2
∑ 𝑝(𝑖, 𝑗) ∗ 2
𝑛𝑟
𝑗
𝑖,𝑗
1
𝑗2
∑ 𝑝(𝑖, 𝑗) ∗ 2
𝑛𝑟
𝑖
𝑖,𝑗
1
2
∑ 𝑝(𝑖, 𝑗) ∗ 𝑗 ∗ 𝑖 2
𝑛𝑟
𝑖,𝑗

Homogeneity
Correlation

𝑖,𝑗

𝑖,𝑗

𝑔(𝑖, 𝑗)
(𝑖 − 𝑗)2
1
+
𝑖,𝑗
𝑔(𝑖, 𝑗) ∗ (𝑖 − 𝜇) ∗ (𝑗 − 𝜇)
∑
𝜎2
𝑖,𝑗
∑

Although run-length matrix is commonly used as a method to extract features from 2dimensional images,22 this becomes computationally intensive, and does not account for
regions that are fully, but not linearly, connected which can be accounted for using low
attenuating clusters.23 Therefore, here we employed a combination of the run-length matrix
with CT cluster analysis by creating a new texture parameter, the cluster volume matrix
(CVM). This is a 3-dimensional analog of the run length matrix, where p(i, j) is the number
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of clusters, i is the gray level, and j is the 3-dimensional cluster size of the same gray level.
The features calculated from the CVM are the same as those calculated from a run-length
matrix, as shown on the left side of Table 3-1. The matrix was populated by binning voxels
into 18 bins between -300 and -1000 HU, where all voxels with values greater than -300
were collapsed into a single bin and all voxels less than -1000HU were included in the
lowest density bin.

3.2.5

Feature Selection

With the intention to avoid model overfitting and maximize model generalizability, a
forward feature selection scheme was developed in MATLAB. As shown in Figure 1B,
training data were divided into five different groups, and five-fold cross validation was
performed using logistic regression, where features were iteratively added based on the
feature that lead to the greatest improvement of the validation area-under-the-curve (AUC),
calculated from the receiver operator characteristic (ROC) curve. As shown in Figure 3-5,
this was performed up to 20 features, as the AUC plateaued to a maximum when 20 features
were used. Features which were in the first 20 features selected for at least two of the fivefold cross-validation steps were included in the final model to ensure the features
consistently contribute to an optimal model.
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Figure 3-5: Details of Training set Outputs.
A) Number of features and validation AUC where features were iteratively included based
on maximal increase to the model during forward feature selection B) Correlation plot for
features included in the final model.
15th percentile=15th percentile of CT Hounsfield Units (HU); CVM = cluster volume
matrix; LGRE=low gray-level run emphasis; RA950=relative area of CT histogram <-950
HU; GLCM=gray level co-occurrence matrix; GLN=gray level non-uniformity;
SRLGE=short run low gray-level emphasis; HGRE=high gray-level run emphasis
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3.2.6

Training the Classification Model

To simplify the anatomical heterogeneity included in the model while maintaining the
information that is representive of the entire lung, we included the centre-most six slices
(of ~15 total slices) that encompass 58±5 percent volume of the lung. In the training set,
the VOI size and sampling scheme were optimized to maximize AUC. The VOI
dimensions were 15 mm in the posterior to anterior direction and were varied from
15x15mm2 to 30x30mm2 in the coronal plane. Due to a greater number of ventilated versus
non-ventilated VOI, the method for sampling VOI to create the training set was critical.
Under-sampling the majority class (ventilated volumes) was used in the training set with
varying methods to ensure that patients with a lower magnitude of ventilation defect
percent were adequately represented in the training data set. To accomplish this, at least as
many ventilated as non-ventilated volumes were randomly sampled from each participant.
Within the training set, to include a balance of patients with large ventilation defects, and
patients with a lower magnitude of ventilation defect percent, a threshold was varied to
define the minimum percentage of the lung sampled (i.e. for threshold=20%, participants
with VDP<20%, ventilated volume sampled=20% of the lung).
Once all parameters and features were selected, 5-fold cross-validation training was
performed using a logistic regression, linear support vector machine (SVM) and a quadratic
SVM. These classifiers were tested as they had greater performance compared to random
forest, linear discriminant and nearest neighbor methods on previous experiments. The data
were standardized and hyperparameter optimization was performed using Matlab
(Classification Learner app) for each model to find the optimal hyperparameters, as
displayed in Table 3-2. The mean cross-validation AUC were used to compare models.
Table 3-2: Quadratic SVM Training Hyperparameters.
The results of hyperparameter optimization for quadratic support vector machine using the
Sequential Minimal Optimization solver, trained using 5-fold cross-validation and
selecting the model with the highest mean validation accuracy.
Metric
Value
Bias
1.2001
Box Constraint
1.0
Kernel Scale
1.8248
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3.2.7

Statistics

All statistical analyses were performed using GraphPad Prism, V8.0 (GraphPad Software
Inc., La Jolla, CA). To determine group differences, unpaired parametric t-tests were used
when the data were normally distributed, and non-parametric Mann-Whitney tests were
used when the data were not normally distributed as tested using the Shapiro-Wilk test for
normality. Pearson correlation coefficients were used to determine the relationships
between model, MRI and pulmonary function measurements. Results were considered
significant when the probability of a two-tailed type I error (alpha) was less than 5%
(p<0.05).

Results
Demographic, pulmonary function tests and imaging measurements provided in Table 3-3
show there were no significant differences between training and testing data sets.
Table 3-3: Participant demographics, pulmonary function and imaging measurements.
Parameter (±SD)
Age years
Female sex %
Pack Years years
FEV1 %pred
FEV1/FVC %
DLCO %pred
SGRQ
RA950 %
VDP %
DSC %

All Participants
n=94
70 (9)
33
50 (30)
63 (25)
51 (13)
56 (23)
40 (18)
10 (10)
12 (12)
95 (1)

Training
n=67
70 (8)
31
49 (29)
63 (25)
51 (13)
54 (21)˄
41 (18)†
10 (10)
12 (11)
95 (1)

Test
n=27
69 (10)
48
50 (27)
61 (24)
51 (13)
57 (22)
37 (20)‡
10 (10)
11 (12)
95 (1)

Difference
p-value
0.6
0.1
0.9
0.6
1
0.7
0.5
1
0.9
0.8

FEV1=forced expiratory volume in 1 second; FEV1/FVC=FEV1 ratio with forced vital
capacity; %pred=percent predicted; DLCO=diffusing capacity for carbon monoxide;
RA950=relative area of CT histogram <-950 HU; VDP=ventilation defect percent;
DSC=dice similarity coefficient for CT-MRI co-registration.
†n=64; ‡n=26; ˄n=66
As shown in Table 3-4, the best performing VOI size was 30x30mm2 while the optimal
sampling threshold required a minimum of 30% ventilated lung, based on the highest AUC
while maintaining the sensitivity once the AUC plateaued. Table 3-4 also shows that by
varying the sampling pattern there was a trade-off between sensitivity and specificity.
60

Therefore, feature selection was performed using 5-fold cross-validation with VOI
dimensions of 30x30x15mm3 and a sampling minimum of 30%.
Table 3-4: Volume of interest and training sample patterns.
To optimize coronal VOI dimensions, the sampling scheme ensured ≥ 30% ventilated lung
was evaluated. To optimize the sampling scheme, for each participant evaluated in the
training set, at least as many ventilated samples as non-ventilated samples were evaluated.
To ensure that disease severity (ventilation, ventilation defects) was represented to train
the model, a minimum percent of the ventilated lung was sampled.
VOI dimensions
15x15mm2
20x20mm2
25x25mm2
30x30mm2
Sampling Scheme
0
10
20
30
40

Validation
Accuracy

Validation Validation
AUC
Sensitivity
Coronal VOI Size
0.440
0.773
0.584
0.784
0.605
0.804
0.485
0.820

81.5
78.6
80.1
85.0
Minimum % Lung Sampled
69.4
0.776
0.729
78.7
0.808
0.661
82.6
0.816
0.576
85.0
0.820
0.485
86.3
0.820
0.382

Validation
Specificity
0.885
0.822
0.833
0.906
0.688
0.807
0.864
0.906
0.937

Table 3-5 shows that first-order density-based features have the largest individual AUC
and both global and ratio values helped optimize the model, where a total of 21 features
were included in the final model. The correlation plot for all included features (Figure
S2B) shows the strong correlation between GLCM features in different directions. During
training, logistic regression, linear SVM and quadratic SVM achieved validation
accuracy/AUC of 85.2%/0.82, 86.3%/0.81 and 87.0%/0.86, respectively. Therefore, the
quadratic SVM model was applied to the test set.
Table 3-5: Features utilized and AUC for training group.
(participants n=67, VOI n=48,313)
Feature
15th percentile global
Skewness global
15th percentile ratio
GLCM Energy [-1,1,1] ratio
GLCM Homogeneity [0,1,0] ratio
Skewness ratio
CVM GLN ratio
RA950 ratio
CVM LGRE global

AUC
0.765
0.505
0.713
0.585
0.570
0.507
0.620
0.711
0.550
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RA950 global
GLCM Energy [1,1,-1] ratio
GLCM Energy [1,0,0] global
GLCM Contrast [1,0,1] global
RA910 global
CVM GLN global
GLCM Energy [1,1,0] ratio
GLCM Contrast [1,0,-1] ratio
CVM SRLGE global
CVM HGRE global
GLCM Correlation [1,0,-1] ratio
Standard deviation ratio

0.761
0.586
0.584
0.588
0.753
0.660
0.583
0.594
0.552
0.570
0.594
0.535

Global=value; ratio=value of VOI feature divided by mean feature value for whole lung;
15th percentile=15th percentile of CT Hounsfield Units (HU); CVM = cluster volume
matrix; LGRE=low gray-level run emphasis; RA950=relative area of CT histogram <-950
HU; GLCM=gray level co-occurrence matrix; GLN=gray level non-uniformity;
SRLGE=short run low gray-level emphasis; HGRE=high gray-level run emphasis.

Figure 3-6 shows the predicted ventilation maps for four subjects within the test set, along
with the experimentally-acquired CT and MRI ventilation scans. A qualitative spatial
agreement between the model ventilation prediction and the MRI ventilation is observed,
as well as noting the magnitude of predicted ventilation defects corresponds to that
observed in the MRI ventilation.
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Figure 3-6: Representative CT, MRI and model outputs for four participants in testing set.
S1: FEV1=116%pred, FEV1/FVC=67%, DLCO=107%pred; S2: FEV1=39%pred,
FEV1/FVC=34%, DLCO =63%pred; S3: FEV1 =25%pred, FEV1/FVC=29%, DLCO =17%pred;
S4: FEV1=30%pred, FEV1/FVC=30%, DLCO =39%pred.
In Figure 3-7, test-set evaluations are shown where the final model achieved an accuracy
of 87.9% and an AUC of 0.82. Figure 3-7 also shows the significant and strong relationship
between model-predicted VDP and hyperpolarized MRI VDP (r=0.90, p=<0.0001) as well
as their significant relationships with FEV1 (Model r=-0.65, p<0.001; MRI r=-0.70,
p<0.0001) FEV1/FVC (Model r=-0.73, p<0.0001; MRI r=-0.75, p<0.0001), DLCO (Model
r=-0.69, p<0.0001; MRI r=-0.65, p<0.001) and SGRQ (Model r=0.59, p<0.005; MRI
r=0.65, p<0.001).
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Figure 3-7: Testing Set Model Outputs and Relationships.
A) Confusion matrix showing the model predicted, and the ground truth MRI
classification, where accuracy=87.9%, AUC=0.82, sensitivity=0.58, specificity=0.92 (VOI
n = 32457); B) Predicted VDP versus the observed VDP (r=0.90, p<0.0001, 𝑦 = 0.65𝑥 +
3). C-F) clinical measures versus model VDP and MRI VDP. DLCO= Diffusing capacity
of the lung for carbon monoxide; VDP= ventilation defect percent; FEV1=forced
expiratory volume in one second; FVC=functional vital capacity; SGRQ=St. George
Respiratory Questionnaire.
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Discussion
We developed a CT analysis pipeline that combined texture feature analysis with machine
learning to generate pulmonary ventilation heterogeneity maps for direct comparison with
MRI ventilation maps acquired in patients. The pipeline was trained and tested in a cohort
of 95 COPD patients in whom volume-matched MRI and CT were acquired within 10
minutes of each other. We made the following observations: 1) the highest performing
model on the training set was applied to the testing set where it classified ventilated and
non-ventilated VOI with 88% accuracy and an AUC of 0.82, 2) there were significant and
strong correlations between model-predicted VDP and MRI VDP, and, 3) both modelpredicted and MRI VDP were significantly related to clinically-relevant measurements in
the same patients including SGRQ, DLCO and FEV1/FVC.
The pipeline we created generated a model that classified ventilated and non-ventilated
volumes with 88% accuracy and an AUC of 0.82. It is important to note that we chose the
parameters and final model based on maximizing the AUC, such that both sensitivity and
specificity of detecting ventilation heterogeneities were considered for algorithm
performance. Density-based first order features generated the largest AUC, which was
consistent with the spatial overlap between emphysema and ventilation defects, and in
agreement with previous experimental results.14, 24 The influence of both global and ratio
features for predicting ventilation underscores the importance of considering disease
severity in relation to the rest of an individual’s lung, and relative to all patient lungs.
Model VDP was strongly and significantly related to MRI VDP. The strong relationship
between model and MRI VDP also provides strong support for the notion that the model
well-predicted a large range of disease severity present within this study. Model-predicted
VDP and MRI VDP were also significantly related to clinically-relevant pulmonary
function measurements, including FEV1/FVC and DLCO as well as SGRQ. This is an
important result in the context of previous automated disease quantification methods
developed using texture analysis,25-29 which were trained using unsupervised learning, or
with previously developed disease classification systems. In contrast, the predicted-model
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trained here provided a quantitative measure that was spatially-dependent and trained using
ventilation as the ground truth.
We acknowledge numerous study limitations including the fact that TINCan comprised a
convenience sample with a large number of moderate to severe patients, so generalizability
should be considered in this context. We also acknowledge that only the centre ~60% of
the lung was included in the analysis in order to simplify CT-MRI co-registration.
Nevertheless, the centre six slices provide an appropriate representation of all five lung
lobes, with a mean VDP difference of 1±2% between the slices we used and whole lung
measurements. CT protocol and scanner image reconstruction may influence texture
features,30, 31 and as such, the generalizability of the trained model presented here to other
scanners and CT acquisition protocols needs to be considered. With that in mind, it is
expected that the inclusion of the normalized features (to whole lung means) may help
mitigate inter-scanner and inter-site variability. While application of our approach to a
multi-centre dataset will evaluate its utility, it is worth noting that many of the densitybased measures such as RA950 and HU15 are already successfully used in clinic as well as
in multi-site studies.32, 33
In 95 patients with COPD, machine learning and texture analysis were used to generate
predicted pulmonary ventilation heterogeneity maps from anatomical thoracic CT and
these maps significantly and strongly correlated with MRI ventilation, pulmonary function
measurements and quality of life. This technology, when externally validated, will enable
widespread generation of ventilation heterogeneity maps using nearly-ubiquitous CT
scanners, providing a novel way to generate ventilation maps beyond the few centres with
hyperpolarized MRI.
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CHAPTER 4

4

CONCLUSIONS AND FUTURE DIRECTIONS

In this final chapter, a summary and overview is provided for the main observations and
conclusions presented in Chapter 2 and Chapter 3. Limitations related to specific studies,
as well as general limitations are provided, along with potential mitigation strategies for
the limitations. Finally, the chapter concludes by discussing future directions for the
methods developed and discussed here.

Overview and Research Objectives
Pulmonary imaging has been used to provide novel insights into COPD, specifically
utilizing hyperpolarized gas MRI for ventilation imaging, which unfortunately, has been
limited in application to date due to the large associated cost. Texture analysis is an
increasingly popular technique for classifying lung disease severity and detecting cancer
in thoracic CT. The overarching objective of this thesis was to develop and apply a texture
analysis pipeline to predict pulmonary ventilation from thoracic CT, thereby extending the
availability of specialized pulmonary ventilation imaging. We postulated the structural
information contained within a single-volume breath hold CT could inform on regional
lung ventilation. The specific research objectives were to first develop a pipeline to perform
texture analysis to predict pulmonary ventilation from thoracic CT, and second, apply this
pipeline in a cohort of COPD patients to generate predicted ventilation maps.

Summary and Conclusions
In Chapter 2, we first proposed the method of using texture analysis to predict pulmonary
ventilation. Here, the pipeline was developed using a small cohort of COPD patients as a
proof-of-concept demonstration. In this small cohort, we observed that utilizing a volume
by volume prediction provided a large number of training samples, which were used to
train a classifier. The observations in this proof-of-concept study demonstrated the
potential of this approach to be applied in a large cohort.
In Chapter 3, we applied, and improved, upon the methods developed in Chapter 2. An
important addition to these methods was the normalization of extracted features to patient
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whole lung values. This allows the model to account for the context of patient disease
severity, as well as the regional disease severity within a patient. 95 patients were
randomized to optimization (n=1), training (n=67) and testing (n=27) datasets. Texture
analysis and machine learning were used to create model-predicted ventilation maps from
CT, which strongly correlated with MRI ventilation maps, DLCO and quality of life
measurements in COPD. These results indicate the potential for the approach presented in
this thesis to be applied in predicting pulmonary ventilation, using widely available CT
protocols.

Limitations
Chapter 2 is a proof-of-concept demonstration of the method developed, and the results
must therefore be taken in that context. The patients within this cohort were hand selected
based on the presence of severe emphysema as determined using CT emphysema measures,
and the presence of a large magnitude of ventilation defects. This was done to enforce a
near equal balance of ventilated and not ventilated samples for training, however, this
strategy also introduced a large bias into the generalizability of the results reported. Despite
choosing patients with similar emphysema and ventilation defect characteristics, there may
be large physiological differences between the training and testing datasets due to a small
sample size. It is therefore difficult to ascertain whether the drop-in performance observed
from training to testing was due to suboptimal selection of parameters (possibly
overfitting), or due to testing on patients that had substantially different disease
manifestation. To address these limitations, a larger, more heterogeneous cohort of patients
should be explored, which allows for a more thorough investigation into the optimal model
parameters.
Chapter 3 addressed many of the major limitations of the study presented in Chapter 2,
including utilizing a larger cohort of COPD patients, however, there were still a number of
limitations. Firstly, the patient data used in the analysis were from the TINCan cohort,
which is comprised of a large number of moderate to severe patients compared to the
general COPD population, and so the generalizability must be considered in this context.
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We also acknowledge that only the centre ~60% of the lung was included in the analysis,
which was done to minimize the anatomical differences within CT. The centre slices are
typically a good representation of the whole lung, and allow for visualization of all five
lobes. To quantify any potential difference this introduced, the VDP for the centre six
slices, as used in this study, was subtracted from the whole lung VDP, and there was an
average difference of 1±2%, which is less than the VDP minimal clinically important
difference of 2%.1 Further, while texture analysis has been widely studied as a promising
method to quantify underlying patterns within medical images, it is known that CT protocol
and scanner image reconstruction may influence textural features,2,

3

and as such, the

generalizability of the trained model presented here to other sites at this time is unknown.
With that in mind, it is expected that the inclusion of the ratio of VOI features to whole
lung feature mean may help mitigate some scanner to scanner variability. The application
to a multi-site dataset is necessary to fully quantify the ability to translate the trained model.
With a dataset taken from multiple scanners, a feature selection step could be included to
select only features which are reproducible across sites. Although a multi-site comparison
is a necessary step towards clinical application of texture analysis, many of the density
based measures such as RA950 and HU15 are already successfully used in clinic as well as
in multi-site studies.4, 5 Due to this wide use, and the fact that the largest contributors to the
model are these density based measures, it is hypothesized the model may be successful in
being generalized to multiple sites.
A general limitation to the work presented in this thesis is the complexity of the prediction
problem being addressed. As discussed, previous studies in COPD have shown there are
hallmark physiological changes, including tissue destruction and airway inflammation.
There are also more recent observations which include vascular abnormalities and airway
pruning. To motivate the work presented here, we have hypothesized these changes will
not be homogenous throughout the lung, but may be more localized within regions of
ventilation defects. This hypothesis has not yet been widely studied, and the notion of
vascular abnormalities within defected regions is a current area of research. Despite the
current limited knowledge of the research related to the underlying hypothesis of this work,
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the texture analysis pipeline and results presented here may be an important tool to explore
questions of the pathophysiological basis of ventilation defects.

Future Directions
4.4.1

Robustness of Texture Model

As mentioned in the limitations, future work must be done to study the generalizability of
the model created to multi-site datasets. Differences in a multi-site dataset that may effect
the texture features include the acquisition parameters, scanner vendor and reconstruction
kernel. Within the TINCan dataset, which was acquired at the same site as the data
presented in this thesis, there is a subset of patients who underwent scans with varying
voxel spacing, ranging from in-plane voxel dimensions of 0.58x0.58mm2 to
0.85x0.85mm2. There are fourteen patients with different voxel dimensions, where images
were acquired with the same scanner, with the same bag-matched breath hold technique,
and with available ground truth hyperpolarized MRI ventilation images. We hypothesize
the first-order measures will transfer well to the study with different voxel spacing,
however the transferability of the second-order features, as well as those normalized to
patient whole lung values, remains unknown. Applying the model generated in Chapter 3
to this subset of patients will allow for conclusions to be drawn on the robustness of the
features to different acquisition parameters.

4.4.2

Lung Function Prediction in Lung Cancer

Patient who undergo radiation therapy for lung cancer require treatment plans for the
delivery of the treatment. Advances in radiation planning and delivery allow for the
possibility to minimize the radiation to certain areas in the lung, and thereby increasing it
to other regions. In lung cancer this can be used to create functional lung avoidance plans,
where the regions within the lung that have the greatest function are spared in the treatment
plan at the expense of regions which are not functioning well, such as ventilation defects.610

The method developed within this thesis may allow for the extraction of this information
from a simple breath hold CT. Lung cancer and COPD are highly related
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epidemiologically,11, 12 and therefore it is hypothesized that the results obtained within this
thesis indicate similar results may be obtained in lung cancer patients. However, additional
complexities will be introduced when training on lung cancer patients. The most obvious
will be the presence of the tumor, and the effect that may have on ventilation, as well as
the fact that the shape, size and location of tumors vary greatly between lung cancer
patients.

4.4.3

Deep Learning for Lung Function Synthesis

There has been a drastic increase in the interest in deep learning for medical image analysis.
Both within, and outside, the medical field convolutional neural networks have shown great
promise for image classification problems. Recently in a large cohort of COPD patients,
deep learning has been applied to create automated disease staging.13 However, this study
also highlights the challenges with deep learning discussed in Section 1.6.1. The large
dataset provided a computational challenge, and subsequently the input data used were
limited to four slices to represent the whole lung, and only a modest success in predicting
disease stage was observed. Despite TINCan not having thousands of images available,
this does provide a benefit as the data is very focused and well understood. Additionally,
utilizing ventilation images as ground truth provides a more spatially and quantitatively
rich measure compared to training to predict a single patient measure such as disease stage.
To apply deep learning to the problem of predicting pulmonary ventilation from single
volume thoracic CT, there are two methods which we hope to explore. The first is by
utilizing a similar pipeline as presented in Chapter 2 and Chapter 3, where the image is
split into volumes of interest, then each VOI is classified as ventilated or not ventilated by
utilizing a CNN with a binary classification as the output layer. Another method is to use
entire CT image as the input, and have the binary ventilation image as the output layer.
Work has been done to create and train architecture for similar tasks of image synthesis,
such as predicting a CT image from an MR image.14, 15
Each method has its own benefits and limitations. If the VOI prediction is used, there will
be a large number of training samples, and it is well known deep learning approaches
increase in performance with a large amount of data. However, this method will not fully
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utilize the spatial relationship between different regions in the image as predictions are
made based only on the local information. For example, it is known mucus plugs within
the lung are associated with ventilation defects,16 however, the ventilation defect will
extend beyond the abnormality if the airflow obstruction is within one of the large airways.
Conversely, the image-to-image synthesis method will be able to more fully account for
the relationship between different regions as the neural network is trained on the entire
lung volume. However, it will be limited to a smaller number of training samples (in both
the case it is trained 2D slice by slice, and especially if trained on the entire 3D volume).
Further, training a 3D neural network with an entire CT as the input will be quite
computationally intensive.
In both methods, it will be possible to leverage transfer learning – where a network is
trained on a larger dataset which allows it to develop the ability to recognize the
fundamentals that make up an image, for example learning edge detection. This is often
utilized in medical imaging, where networks are trained on large, open-source labeled
datasets such as ImageNet. It is hypothesized that an intermediate stage of transfer learning
may help with the adaptation to medical images. In this case, there are large open-source
labeled datasets of planar chest x-rays.17 A network originally trained on natural objects in
ImageNet, may be applied and fine-tuned to classify the planar chest x-rays, conceivably
learning to detect more subtle abnormalities that are seen within lung diseases. This
network may then be applied to classify image VOI, or as the encoder/decoder weight
initialization for an image synthesis network.

Significance and Impact
In patients with chronic obstructive pulmonary disease (COPD), structural remodeling of
the airways, airway inflammation/obliteration and parenchyma destruction commonly
result from chronic inhalation of combustibles including tobacco cigarettes and biomass
fuels.18 Pulmonary x-ray computed tomography (CT) is now widely used to visualize and
quantify COPD structural lung abnormalities and these measurements have been exploited
in large cohort studies. Hyperpolarized 3He and 129Xe magnetic resonance imaging (MRI)
pulmonary measurements also provide high spatial and temporal resolution lung
ventilation heterogeneity and microstructural information in COPD patients. The most
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significant limitation to the widespread application of these techniques is that they are
scarcely available due to the high cost of such technology. The methods and models
generated in this thesis, when externally validated, will enable translation of ventilation
heterogeneity maps using nearly-ubiquitous CT scanners, providing a novel way to
generate ventilation maps beyond the few centres with hyperpolarized MRI.
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APPENDIX
Appendix A – Hyperpolarized 3He MRI Ventilatory Apparent Diffusion Coefficient
of Alpha-1 Antitrypsin Deficiency
In Appendix A we developed a new 3He MRI biomarker of emphysema which
incorporates both abnormal ventilation heterogeneity and the apparent diffusion
coefficient (ADC) – this biomarker overcomes limitations in longitudinally following
emphysema progression using ADC.
The contents of this chapter have previously been published in Journal of Magnetic
Resonance Imaging and permission to reproduce the article was granted by John Wiley
and Sons and is provided in Appendix C.
A Westcott, DPI Capaldi, A Ouriadov, DG McCormack and G Parraga. Hyperpolarized
3
He MRI Ventilatory Apparent Diffusion Coefficient of Alpha-1 Antitrypsin Deficiency.
JMRI. 10.1002/jmri.26202.
To the Editor:
Alpha-1 antitrypsin deficiency (AATD) leads to disabling chronic obstructive pulmonary
disease (COPD). Current therapy aimed at slowing lung disease progression includes
exogenous alpha-1 antitrypsin augmentation therapy but there are few potential new
treatments under development.

Currently used measurements of AATD-related

emphysema include the forced expiratory volume in 1 second (FEV1) and the diffusing
capacity of carbon monoxide (DLCO); both are relatively insensitive to therapy1 although
CT lung density measurements have been shown to worsen more slowly in treated
patients.2
Hyperpolarized magnetic resonance imaging (MRI) has emerged as a possible alternative
or complementary method for evaluating lung microstructure and function.3 Longitudinal
worsening of MRI ventilation-defect-percent (VDP) was shown to be related to symptoms
and exercise capacity in COPD patients in whom FEV1 was not predictive.4 The apparent
diffusion coefficient (ADC) measured using 3He and

129

Xe

MRI has also been

demonstrated in patients with AATD.5 Although 3He MRI ADC is highly reproducible,6
these values only report from well-ventilated lung which is important because as AATD
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emphysema worsens over time, no inhaled gas MRI information can be gleaned from
unventilated lung regions.
Our goal was to develop a new biomarker of AATD emphysema that incorporates
functional and microstructural abnormalities which would be sensitive to disease changes
over time. We evaluated a single patient with a clinical diagnosis of AATD, who provided
written informed consent to study protocols (registered at clinicaltrials.gov as
NCT02279329 and NCT02723474) approved by a local research ethics board and federal
regulatory agency. He was evaluated using spirometry, plethysmography according to
guidelines7 and MRI at each visit; he also completed the St. George Respiratory
Questionnaire (SGRQ) and six minute walk test (6MWT) and thoracic CT on a 64-slice
Lightspeed VCT scanner (General Electric Healthcare, Milwaukee, WI) (64 × 0.625 mm,
120 kVp, 100 effective mA, tube rotation time = 500 ms, and pitch = 1.0) in breath-hold
after inhalation of a 1-L N2 bag from FRC on visits 2, 4 and 6. The total effective dose
was 1.8 mSv (Health Protection Agency of the United Kingdom NRPB-SR250). MRI was
performed on a 3T system (MR750 Discovery, GEHC, Milwaukee, WI) as previously
described6 using a multi-slice interleaved 2-dimensional gradient echo diffusion-weighted
sequence for seven 30-mm coronal slices (900 µs selective radio frequency pulse, flip angle
θ = 4°, echo time = 3.9 ms, repetition time = 5.6 ms, bandwidth = 62.5 kHz, in-plane
resolution = 3.125 × 3.125mm2, b = 0, 1.6 s/cm2); the diffusion-sensitization gradient pulse
ramp up-down time=500 µs and diffusion time=1460 µs.
The relative area of the CT density-histogram with values < -950 HU (RA950) and MRI
ventilation-defect-percent (VDP) were measured using custom-built (MATLAB R2014b;
MathWorks, Natick, Mass) software.8 ADC maps were generated using 3He diffusionweighted images as previously described.9 To determine regional information, the apical
region was segmented from the basal region based on the location of the carina.
It was previously shown in patients with severe COPD that ventilation defects spatially and
quantitatively correlated with emphysematous bullae10 which reinforces the notion that
lung regions with severe emphysema have long time-constants for filling and cannot be
ventilated during a short breath-hold scan. To account for this, we considered the diffusing
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capacity of the lung for carbon monoxide (DLCO) normalized to the ventilated alveolar
volume, which generates KCO, as shown in equation 1:
𝐾𝐶𝑂 =

𝐷𝐿𝐶𝑂

(1)

𝑉𝐴

where 𝑉𝐴 is the alveolar volume, or the “accessible” volume available for gas exchange. In
a similar manner, we proposed to normalize ADC in relation to ventilation, which we term
the ventilatory ADC (vADC) as:
𝑣𝐴𝐷𝐶 =

𝐴𝐷𝐶
1−

𝑉𝐷𝑃
100

(2)

We prospectively evaluated a single AATD patient who attended six visits over a 65 month
period and received augmentation therapy for the duration of the study, except for a few
months between visit 3 and visit 4. At the first visit where quality of life measurements
were recorded, the 6MWD was normal. As shown in Figure 1A, measurements were
evaluated using linear regression with the time as the independent variable to calculate
slope, r2 and p-value. 3He MRI ventilation and ADC maps show there was qualitative,
visually-obvious evidence of increasing ADC values in the apical lung regions and
enlarged ventilation defects in the basal lung regions. In Figure 1A and Figure 1C, FEV1
(slope=-1.8, r2=0.94, p=0.001), RA950 (slope=0.86, r2=1, p=0.02), vADC (slope=0.03,
r2=0.77, p=0.02), and VDP (slope=2.7, r2=0.79, p=0.02) significantly changed over time
(significant non-zero slope). However, DLCO (p=0.70), ADC (p=0.20) and FEV1/FVC
(p=0.05) did not significantly change. These results, along with other important measures,
are reflected in the quantitative results shown in Figure 1B.
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Figure 1: A) Longitudinal imaging measurements and 3He MRI static ventilation (cyan)
coregistered with 1H MRI; 3He MRI apparent diffusion coefficient (ADC) maps; Thoracic
CT RA950 maps; B) Participant measurements over 65 months; C) Clinical pulmonary
function measurements, 95 % confidence intervals shown for significant regressions.
FEV1=forced expiratory volume in 1 second; %pred=percent predicted; FVC=forced vital
capacity; DLCO=diffusing capacity of the lungs for carbon monoxide; 6MWD=Six minute
walk distance; VDP=ventilation defect percent; ADC=apparent diffusion coefficient;
RA950=relative area of the CT density histogram of attenuation values <-950 Hounsfield
Units; vADC=ventilatory ADC.
In this proof of concept demonstration, it is important to note that vADC was generated
and used based on the assumption that in patients with advanced COPD, ventilation defects
are dominated by emphysematous bullae and not airways disease.10 This is certainly also
the case in AATD patients where emphysematous destruction dominates. However, in
patients with mild COPD, ventilation defects also derive from gas trapping due to smallairways disease10 and for these patients, different weightings of the ratio of ADC and VDP
should be generated and tested. In this specific AATD patient with GOLD grade 2 COPD
and severe emphysema, vADC, and VDP as well as apical ADC, RA950, 6MWD and FEV1
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significantly changed over the 65 month followup period. Somewhat surprisingly, this was
not the case for DLCO, perhaps because it can be highly variable over time.
We also observed that vADC significantly increased in both apical and basal regions,
whereas VDP did not significantly change in the apical regions and ADC did not
significantly change in the basal lung regions. These findings are certainly consistent with
previous longitudinal MRI results in COPD patients in whom worsening emphysematous
bullae resulted in larger ventilation abnormalities as disease progressed. We acknowledge
that vADC has not been widely tested yet and a large scale study is required in patients
with severe emphysema that includes both KCO and patient outcomes. Nevertheless, this
preliminary study in a single AATD patient showed that vADC significantly changed while
ADC did not. Moreover, vADC changes were concordant with significantly worse 6MWD
and CT measurements which supports its use as a biomarker of airspace enlargement in
patients with severe emphysema.
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Appendix B - Rapid Single-breath Hyperpolarized Noble Gas MRI Based
Biomarkers of Airspace Enlargement.
In Appendix B we used accelerated 129Xe MRI to generate alveolar morphometry
estimates in patients with COPD and alpha-1 antitrypsin deficiency. The use of
accelerated MRI allows for collection of the data in a single breath-hold scan, versus
multiple-breath methods previously used. I was co-first author on this work with my
colleague Fumin Guo.
The contents of this chapter have previously been published in Journal of Magnetic
Resonance Imaging and permission to reproduce the article was granted by John Wiley
and Sons and is provided in Appendix C.
A Westcott, F Guo, G Parraga and A Ouriadov. Rapid single-breath hyperpolarized
noble gas MRI-based biomarkers of airspace enlargement. 10.1002/jmri.26574.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD), characterized by both small airway
dysfunction and airspace enlargement, is a leading cause of morbidity and mortality and is
responsible for 700,000 costly hospitalization days annually in the United States.1
Important and promising work with 3He MRI has led to the development of physiologically
relevant biomarkers of obstructive lung disease including the apparent diffusion coefficient
(ADC) and mean linear intercept (Lm), derived from multi-b diffusion weighted MRI and
utilized to probe the microstructure of the lung.2 Due to the increasing scarcity and cost of
3

He, the continuation of hyperpolarized gas imaging necessitates decreasing the number of

3

He doses or moving towards the use of 129Xe.3-5 However, the low gyromagnetic ratio of

129

Xe and the gradient strengths typical for clinical scanners (5G/cm) dictate that rapid MRI

acquisition strategies be developed to facilitate the uptake of

129

Xe diffusion-weighted

imaging.6 This is especially true for multi-b diffusion-weighted MRI because currently,
whole lung datasets are difficult to acquire during the relatively short 10-16 second breathhold timeframe7 feasible in patients with lung disease. However, it was recently
demonstrated8 that 6 b-value, lower spatial resolution (7x7x30mm3 voxels) whole-lung
coverage can be achieved in 10 seconds using a GRAPPA approach with a dedicated,
phased receive-array coil system.
Previously, three-dimensional multi-b diffusion-weighted MRI9 required a number of
independent doses of gas for each slice as typically 4 or 5 different b values (including 0)
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are required in order to generate curves with sufficient data for analysis and each of these
b values requires a single breath-hold image with freshly inhaled gas contrast,7 culminating
in a total of three xenon doses. This is an important cost and time/patient effort issue.
Therefore, the ability to accelerate the acquisition has the potential to provide cost savings
in two critical areas: the cost of the xenon gas, and the time needed for the scans. Each
xenon dose costs approximately $250 US (1L of 50/50

129

Xe/4He, 86% enriched), in

addition to an average collection time of 20 minutes per xenon bag, necessitating at least
an hour of personnel and patient time for three separate scans. Further, multiple scans can
lead to lung volume variability and patient distress or fatigue. While a multi-breath
approach has been feasible in small research studies, the increased time for acquisition, the
potential for lung volume mismatch and repeated doses of hyperpolarized gas will likely
not be compatible with larger scale clinical examinations or use. Recently, a stretchedexponential-model10 combined with under-sampling in the imaging and diffusion
directions11 was proposed for the evaluation of hyperpolarized gas multiple b-value
diffusion-weighted MRI.

The major advantage of this method is the possibility to

significantly speed up data acquisition using acceleration factors (AF) between 7 and 10.11
This is potentially more rapid than the compressed-sensing methods recently published for
diffusion-weighted MRI10 and also provides high spatial resolution images. This approach
provides a method to generate four non-zero b-values for diffusion-weighted 129Xe MRI in
a single breath-hold, or alternatively be applied to combine 3He static ventilation and multib diffusion weighted scans into a single breath-hold. We hypothesized that a previous
method11 could be extended to provide whole lung hyperpolarized gas MRI-based
emphysema biomarkers for 3He and

129

Xe, including static-ventilation (SV), T2*,12 ADC

and morphometry maps with high spatial image resolution. Therefore, in this proof-ofconcept evaluation, our objective was to develop a rapid, cost-efficient and patient friendly
approach that generates emphysema biomarkers in a small group of patients with
emphysema.

THEORY
In pulmonary diffusion MRI, the limitations of non-renewable gas hyperpolarization,
breath-hold duration, and the inherently longer diffusion-weighted scans have motivated
86

the development of rapid image acquisition and reconstruction techniques. Accordingly,
previous efforts have focused on accelerated image acquisition including parallel imaging,
compressed sensing, deep learning and combinations of these approaches. For example,
k-t methods (e.g., k-t BLAST/SENSE) represent a model-based approach that employs the
prior information of signal covariance matrix from training data to improve image
resolution.13 K-t methods were also combined with compressed sensing (e.g., k-t SPARSE,
k-t FOCUSS) to reconstruct high spatial-temporal resolution images with minimal aliasing
artefacts from under-sampled data. In particular, k-t FOCUSS14 comprises of a prediction
step, a residual encoding step, and the optimal sample allocation between the two. Another
model-based approach, MARTINI,15 employs mono-exponential T2 decay as prior, and
directly estimates tissue properties (T2 and spin density) from a set of under-sampled kspace data using a nonlinear inverse reconstruction algorithm. Other approaches including
SAKE,16 LORAKS17 and ALOHA18 arrange k-space data into a structured annihilating
filter-based Hankel matrix and employ the low-rankness of the matrix for image
reconstruction. In particular, SAKE investigates the correlation between multiple receiver
coils, LORAKS requires finite spatial support and smooth phase prior, ALOHA relates
transform sparsity to low-rankness of the Hankel matrix in the Fourier domain and
reconstructs images through matrix completion. Here we employed a compressed sensingbased framework with a Split Bregman numerical solver to reconstruct high resolution
images from under-sampled k-space data by exploiting the implicit spatial and b-value
sparsity of MR images.
We denote 𝐼 = {𝐼1𝐻 , 𝐼2𝐻 … 𝐼𝑁𝐻 }𝐻 as the N ventilation images that we aim to reconstruct from
undersampled k-space data 𝑓 = {𝑓1𝐻 , 𝑓2𝐻 … 𝑓𝑁𝐻 }𝐻 corresponding to the N b-values, where H
represents Hermitian transpose. Here the spatial sparsity of each diffusion MR image is
mathematically formulated using total variation (TV) of the image, i.e. |∇𝐼𝑖 |. In addition,
the sparsity along the 𝑏-value direction can be regarded as the gradient of diffusion MR
images 𝐼𝑖 and 𝐼𝑖−1 acquired at adjacent 𝑏-values 𝑏𝑖 and 𝑏𝑖−1 , 𝑖 = 2 … 𝑁, i.e.,
̅ −(𝐷
𝛼
̅𝑏

𝑀𝐼𝑖 = 𝐼𝑖 − 𝐼𝑖−1 ∙ 𝑒 −((𝐷̅𝑏𝑖 )

̅
𝛼
𝑖−1 ) )

,[1]

̅ and 𝛼̅ are the mean diffusivity and heterogeneity values, respectively, and can be
where 𝐷
estimated from previously acquired images.11 To this end, we proposed to reconstruct the
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images 𝐼 from undersampled k-space data 𝑓 in both the spatial and b-value directions while
maintaining data consistency as follows:
𝜇
min 𝛼‖∇𝐼‖1 + 𝛽‖𝑀𝐼‖1 + ‖𝐹𝐼 − 𝑓‖2 ,[2]
𝐼
2
where 𝑀 is the linear operator defined in Eqn. [1], 𝐹 represents the undersampled Fourier
transform, 𝛼, 𝛽 and 𝜇 are positive constants that balance the weight of three terms.
The unconstrained TV-ℓ1 /ℓ2 optimization problem in Eqn. [2] was solved using a Split
Bregman algorithm19 and we note that it can also be solved using convex optimization
techniques.20 The Split Bregman algorithm introduces a number of dummy variables, i.e.,
𝑑𝑥 = ∇𝑥 𝐼, 𝑑𝑦 = ∇𝑦 𝐼 and 𝑚 = 𝑀𝐼, for each constraint weighted by constant 𝜆. The Split
Bregman algorithm iterates in two phases until convergence:
1. (𝐼 𝑘+1 , 𝑑𝑥𝑘+1 , 𝑑𝑦𝑘+1 , 𝑚𝑘+1 ) = arg min 𝛼‖𝑑𝑥 ‖ +𝛼‖𝑑𝑦 ‖ + 𝛽‖𝑚‖ +
𝐼,𝑑𝑥 ,𝑑𝑦 ,𝑚

𝜇
2
𝜆

‖𝐹𝐼 − 𝑓 𝑘 ‖2 +
2

𝜆

𝜆

𝑘 ‖2
‖𝑑𝑥 − ∇𝑥 𝐼 − 𝑏𝑥𝑘 ‖2 + ‖𝑑𝑦 − ∇𝑦 𝐼 − 𝑏𝑦𝑘 ‖ + ‖𝑚 − 𝑀𝐼 − 𝑏𝑚
. This step can be
2
2
2

spilt into several subproblems each optimizing a single variable sequentially because
these variables are independent from each other. In particular, the subproblem of 𝐼
involves only ℓ2 -norm and can be solved analytically.
𝑘+1
𝑘
𝑘+1
𝑘+1
𝑘
2. Update the dummy variables as: 𝑏𝑥,𝑦
=  𝑏𝑥,𝑦
+ ∇𝑥,𝑦 𝐼 𝑘+1 −  𝑑𝑥,𝑦
, 𝑏𝑚
=  𝑏𝑚
+

𝑀𝐼 𝑘+1 −  𝑚𝑘+1 and 𝑓 𝑘+1 = 𝑓 𝑘 + 𝑓 − 𝐹𝐼 𝑘+1 .
The signal dependence related to diffusion-sensitization can be determined through the
probability density function or diffusion propagator (P) for fluid diffusion in confined
media with unknown geometry:21-23


S( b) / S0 =  P( D) exp( − D  b ) dD

[3]

0

where S(b) is the signal at a particular b-value and S0 is the MR signal-intensity in the
absence of diffusion-sensitizing gradients. The diffusion propagator can be ascertained
through the inverse Laplace transform of S(b)22 and to apply this, the analytical
representation for S(b) is required.

Thus, experimental S(b) values can be fit as

demonstrated for multi-b diffusion-weighted 3He MRI10, 11, 23 as follows:
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S( b) / S0 = exp( −D  b)

[4]

where D is the apparent diffusivity and α is the heterogeneity index (0<α≤1.0). The
diffusion propagator can be determined through substitution of Eqn. [4] into Eqn. [1] and
then applying the inverse Laplace transform:22

 (1 − )  /(1− ) 
P( D) =
exp −
 f ( D)
 /(1− )
( D / D)(1− / 2) /(1− )
 ( D / D)


[5]

B / D

 1 /[1 + C ( D / D) (0.5 − 2 ) /(1− ) ],

   0.5,
f ( D) = 
2
 1 + C ( D / D) (0.5− ) /(1− ) ,

   0.5

And

[6]

where f(D) is the auxiliary function and parameters B and C are functions of the
heterogeneity index.22 Mean D estimates can be determined using the probability density
function distribution to calculate specific to acinar duct mean diffusion length maps21
(LmD = √2∆D, where ∆ is the diffusion time and D is the diffusivity). For multi-b
diffusion-weighted 3He MRI, Lm is empirically observed to be proportional to LmD:23

Lm = − 562 m + 4.3 Lm D

[7]

LmD depends on both diffusion time and diffusivity, so Eqn. [7] cannot be used for
MRI-based Lm estimates.

In order to extend Eqn. [7] to

129

129

Xe

Xe gas, the empirical

relationship in Eqn. [8] was previously determined and proposed:24

2D0He  He
L m = − 562 m + 4.3  Lm D 
2D0Xe  Xe

[8]

He
where D 0 is the diffusion coefficient of 3He (0.88 cm2/s) in gas mixture, ΔHe=1.46 ms,

D 0Xe is the diffusion coefficient of 129Xe (0.12 cm2s-1/0.14 cm2s-1 25) in gas mixture and ΔXe
is the diffusion time.

MATERIALS and METHODS
Study Participants
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We enrolled 12 participants, including four never-smokers, four COPD ex-smokers with
emphysema and one alpha-1 antitrypsin deficiency (AATD) patient with COPD who were
included in the retrospective study as well as three COPD ex-smokers with emphysema
who were included in the prospective study; all provided written informed consent to an
ethics board-approved protocolthat was compliant with the Health Insurance Portability
and Accountability Act (HIPAA, USA). Ex-smokers with COPD and AATD patients with
COPD were enrolled between 50-80 years of age; never-smokers without a history of
tobacco smoking or chronic respiratory disease were enrolled between 45-80 years of age.
Pulmonary Function Tests and CT
Spirometry,

plethysmography

and

the

diffusing-capacity-of-the-lung-for-carbon-

monoxide (DLCO) were performed according to American Thoracic Society (ATS)
guidelines26 using a plethysmograph and attached gas analyzer (MedGraphics Corporation.
St. Paul, MN USA). X-ray computed tomography (CT) was also performed supine (64slice Lightspeed VCT scanner GEHC, Milwaukee, WI USA; 64×0.625 mm, 120 kVp,
effective mA=100, tube rotation time=500 ms, pitch=1.0) using a spiral acquisition in
breath-hold after inhalation of 1L N2 from functional residual capacity (FRC). A slice
thickness of 1.25 mm and standard convolution kernel were used.
129Xe

and 3He MRI Acquisition

MRI was performed at 3T (MR750, GEHC, Waukesha WI) using whole-body gradients
(Gmax=5 G/cm, slew rate=200 mTm-1s-1) as previously described.7

129

Xe gas (86% enriched,

measured polarization 12-40%) was provided by commercial polarizer systems (XeBoxE10, Xemed LLC, Durham, NH; XeniSpin™, Polarean Inc, Durham, NC). All subjects
inhaled 1L of a 50/50 by volume 129Xe/4He gas mixture from functional residual capacity
(FRC). In all xenon measurements the diffusion-sensitization gradient pulse ramp up/down
time=500 μs, constant time=2 ms, ΔXe=5 ms, providing four b-values 0, 12.0, 20.0, and
30.0 s/cm2. Three 129Xe doses were used in the diffusion-weighted measurements, except
for a single AATD patient who could not undertake multiple breath-holds, and in whom
data was acquired in a single xenon dose at a lower resolution to obtain whole lung
coverage with a diffusion-weighted, whole lung 3D FGRE pulse sequence. For patients
with COPD and never-smokers, two interleaved acquisitions (diffusion-weighted, multislice 2D Fast Gradient Recall Echo (FGRE) pulse sequence (similar to Figure 1A),
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TE/TR=9.8msec/11.0msec,

matrix

size=128x80,

number

of

slices=7;

slice

thickness=30 mm, and FOV=40x40 cm2) one with and one without diffusion-sensitization
(i.e. b=0 and b=12 s/cm2 or b=0 and b=20 s/cm2 or b=0 and b=30 s/cm2) for each line of kspace in each image slice were acquired to ensure that RF depolarization (optimal 5o constant
flip angle was used) and T1 relaxation effects were minimal.7 For 129Xe MRI in the AATD
patient, four interleaved acquisitions (diffusion-weighted, whole lung 3D FGRE, 0.5ms
rectangular RF pulse, VFA, TE/TR=9.0msec/10.0msec, matrix size=64x64, number of
slices=8; slice thickness=30 mm, and FOV=40x40 cm2). Four interleave cycles were
initiated at the maximum b-value (b=30s/cm2) to ensure that maximum MR signal was
acquired at greater b-values as previously described.23
For 3He MRI, polarized 3He gas (polarization ~40%) was provided by a commercial system
(HelispinTM, Polarean Inc, Durham, NC 27). Subjects inhaled 1L of a 3He/N2 a gas mixture
(30/70 by volume) from FRC as previously described.28 For 3He MRI, an accelerated
(AF=7) multi-slice interleaved (six interleaves) centric 2D FGRE diffusion-weighted
sequence (Figure 1A and B) under-sampled in the imaging and diffusion direction as it is
shown in Figure 1C (bottom panel)11 was acquired for seven 15mm coronal slices
(reconstructed matrix size=128x128, total acquisition time=12 s, 0.9 ms selective RF
pulse, TE/TR=4.1ms/5.6ms, bandwidth=62.5 kHz, FOV=40x40 cm2, b=0, 1.6, 3.2, 4.8,
6.4 s/cm2). An optimal 7.4o constant-flip-angle (120 [20 per b-value] RF pulses per slice)
was used.
Figure 1 outlines the pulse sequence used and the k-space sampling method, where the
sparsity occurs in the diffusion direction, as shown using the varying sampling patterns for
different b-value images. The diffusion-sensitization gradient pulse ramp up/down
time=0.5 ms with ΔHe=1.46 ms which was initiated at the maximum b-value to ensure that
maximum MR signal was acquired at greater b-values as previously described.23
Additionally, a short-TE (TE=1.3ms) b=0 image was used to generate the SV image and
T2* map. A single breath-hold was used to generate all 3He maps.
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Figure 1: MRI Pulse Sequence Schematic, Sparsity Pattern and Reconstructed 3He Images
A) Diffusion-Weighted, Multi-Slice 2D Fast Gradient Recall Echo (FGRE) pulse sequence
with diffusion-sensitizing along z-direction. Δ=1.46ms, TE=4.1ms. Five interleaves,
starting at the maximum b-value (6.4 s/cm2) ensures multiple b-value approach; B) An
extra interleave with no diffusion-weighting (b=0) and significantly reduced TE (1.3ms)
utilized to generate a short TE static ventilation image and T2* map by using a long TE
static ventilation image (b=0) from A); C) k-space under-sampling scheme (bottom panel),
ensuring a variety of sparsity patterns for each b-value (AF=7) employed in diffusion
direction, with resulting images where the signal decay with higher diffusion
gradient induced signal decay is evident. A short TE static ventilation image, a long TE
static ventilation image and four diffusion-weighted images (top panel) shown from left to
right. The SNR value varies from 35 (short TE static ventilation image) to 4 (maximum bvalue image).
Image Analysis
129

Xe data were retrospectively under-sampled in both imaging and diffusion directions

ensuring AF=7 to validate the reconstruction method11 and using the regularization
parameters previously determined.19 A single slice (six images) reconstruction was
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completed within approximately 2-3 minutes using Matlab 2016 on a standard PC
workstation with 3.0GHz CPU using a previously developed approach.11 The ADC (b=0
and 12 s/cm2) and morphometry maps ((LmD),10 mean-linear-intercept (Lm)23) were
generated as previously described11, 23 and compared with corresponding maps calculated
for the fully-sampled k-spaces. 3H MRI data were reconstructed as previously described,11
and static-ventilation (short-TE image), T2* (TE1/TE2=1.3ms/4.1ms), ADC (0 and
1.6 s/cm2)

and morphometry (LmD/Lm) maps were generated.

(MATLAB R2017

MathWorks, Natick, MA) was used to generate all hyperpolarized gas maps. Image SNR
was calculated using a 15x15 voxel square region of interest inside a lung region of
homogeneous signal and using the same 15x15 voxel square region of interest outside the
lung where there is no lung signal.29
A semi-automated segmentation approach was used to generate ventilation defect percent
(VDP), as previously described.30 ADC maps were generated for two b-values on a voxelby-voxel basis as previously described.4 The relative area of the CT density histogram
with attenuation values <-950 Hounsfield units (RA950)31 was determined using Pulmonary
Workstation 2.0 (VIDA Diagnostics Inc., Coralville, IA).
Statistics
Differences between ADC and Lm values generated from fully and undersampled k-space
were calculated on a voxel-by-voxel basis for a single slice10 using Eqn. [9]:
N

M

Difference = [

FullySamp led ij − Undersam pled ij

i =1 j=1

FullySampl ed ij

]  100%

[9]

where N and M are the corresponding image matrix sizes. Multivariate analysis of variance
(MANOVA) and independent t-tests were performed using SPSS Statistics, V22.0 (SPSS
Inc., Chicago, IL). Results were considered significant when the probability of two-tailed
type I error () was less than 5% (p<.05).

RESULTS
Table 1 summarizes pulmonary function, CT and demographic measurements for all
participants. Figure 1C (top panel) shows representative images reconstructed from the
under-sampled data in the imaging and diffusion direction of k-space (bottom panel, AF=7)
including a short TE static ventilation image, a long TE static ventilation image and four
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diffusion-weighted images shown from left to right. The SNR value varied from 35 (short
TE static ventilation image) to 4 (maximum b-value image).
Table 1: Participant demographic and imaging measurements.
Emphysema Subjects
Parameter
(n=8)
Never-Smokers
(Mean±SD)
(n=4, 129Xe)
COPD
COPD
AATD
(n=3, 3He)
(n=4, 129Xe)
(n=1, 129Xe)
Male Sex n (%)
3(100)
3 (75)
1 (100)
2 (50)
Age years
81 (6)
68 (10)
67 (-)
66 (13)
FVC %pred
104 (40)
100 (21)
102 (-)
102 (8)
FEV1 %pred
89 (37)
58 (30)
55 (-)
103 (6)
FEV1/FVC %
82 (84)
42 (14)
40 (-)
76 (2)
RV %pred
46 (43)
160 (57)
170 (-)
102 (9)
TLC %pred
60 (50)
123 (8)
130 (-)
102 (8)
RV/TLC %pred
50 (43)
48 (14)
131 (-)
39 (9)
DLCO %pred
56 (6)
39 (13)
50 (-)
104 (12)
VDP %
20 (6)
28 (14)
4 (.3)
RA950 %
19 (9)
COPD=ex-smoker with COPD; FEV1=forced-expiratory-volume-1-sec; %pred= percentpredicted; FVC=forced-vital-capacity; RV=residual-volume; TLC=total-lung-capacity;
DLCO=diffusing capacity of the lung for carbon monoxide; VDP=ventilation defect
percent; RA950=relative area of the CT density histogram < - 950 Hounsfield units
Figure 2 shows centre coronal slice CT and MRI ventilation images as well as MRI ADC
and Lm maps for a representative never-soker, COPD and AATD patients obtained for
fully-sampled and retrospectively accelerated methods.

CT images reflected low

attenuating areas (<-950 HU) in the COPD/AATD patients with RA950=12% and 19%
respectively, where the AATD CT is from a visit 19 months prior.
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Figure 2: Representative CT and 129Xe MRI Maps
SV=MRI static ventilation; ADC=apparent-diffusion-coefficient; Lm=MRI mean-linearintercept; ADCA=ADC obtained with accelerated approach; LmA= Lm obtained with
accelerated approach.
NS=Elderly
never-smoker,
FEV1=105%pred,
DLCO=94%pred,
RA950=0.14%,
A
2 -1
2 -1
A
ADC/ADC =0.05cm s /0.05cm s , Lm/Lm =300µm/280µm, VDP=3.92%;
COPD=Ex-smoker with COPD, FEV1=59%pred, DLCO=43%pred, RA950=12%, ADC/ADCA
=0.08cm2 s-1/0.08cm2s-1, Lm/LmA=540µm/550µm, VDP=15%;
AATD=alpha-one antitrypsin deficiency, FEV1=58%pred, DLCO=50%pred, RA950=19%,
ADC/ADCA =0.08cm2 s-1/0.09cm2s-1, Lm/LmA=580µm/570µm, VDP=27%.
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Table 2 summarizes

129

Xe airspace enlargement biomarkers calculated from the center

slice, ADC and Lm, for all

129

Xe study participants. Mean ADC/ADCA, (A=acceleration)

and Lm/LmA estimates for the never-smokers (0.05cm2s-1/0.05cm2s-1 and 290µm /280µm)
were significantly smaller than the corresponding mean estimates for COPD/AATD
patients (0.09cm2s/0.09cm2s and 540µm/530µm; all p<.001) for fully-sampled and
accelerated methods. For the never-smoker subgroup, a mean difference of 14%/12% was
observed between the fully-sampled and the accelerated approach for the ADC and Lm
values, respectively. For the COPD subgroup a mean difference of 12%/8% was observed
between fully-sampled and accelerated data ADC and Lm values, respectively. For the
AATD subject a mean difference of 11%/9% observed between fully-sampled and
accelerated data ADC and Lm values, respectively.
Table 2: 129Xe MRI Parenchyma Measurements and Morphometry Estimates.
ADC
cm2/s

ADCA
cm2/s

Lm µm

LmA µm

.05 (.01)

.05 (.01)

290 (100)

280 (110)

14%

12%

NS-1

.04 (.01)

.05 (.01)

310 (90)

320 (80)

9%

10%

NS-2

.05 (.02)

.05 (.01)

280 (110)

260 (90)

16%

14%

NS-3

.04 (.01)

.04 (.01)

280 (90)

280 (150)

16%

12%

NS-4

.05 (.01)

.05 (.01)

300 (120)

280 (100)

15%

13%

COPD

.09 (.02)

.08 (.01)

490 (120)

480 (250)

12%

8%

COPD-1

.10 (.02)

.10 (.01)

500 (130)

480 (120)

12%

8%

COPD -2
COPD -3

.08 (.02)
.08 (.02)

.08 (.01)
.08 (.01)

540 (100)
450 (120)

550 (90)
440 (100)

9%
13%

6%
8%

COPD -4

.09 (.03)

.08 (.02)

490 (140)

480 (120)

16%

9%

.08 (.02)

.09 (.02)

580 (140)

570 (130)

11%

9%

<0.001

<0.001

<0.001

<0.001

0.4

<0.01

Never-Smoker

AATD
NS-COPD/AATD
p-value

ADC
Lm
difference difference

NS= Never-Smokers; COPD=COPD ex-smoker; AATD=alpha-one antitrypsin
deficiency; ADC=apparent-diffusion-coefficient; Lm=MRI mean-linear-intercept;
ADCA=ADC obtained with accelerated approach; LmA= Lm obtained with accelerated
approach.
Figure 3 shows representative center slice SV, T2*, ADC, LmD and Lm maps for three
COPD subjects reconstructed from the originally under-sampled k-space (AF=7). Table 3
shows mean estimates of T2* ADC, LmD and Lm and the signal-to-noise (SNR) values for
b=0/b=6.4s/cm2 images and SV image used to calculate ventilation-defect-percent.4
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Figure 3: Representative 3He MRI Maps obtained for COPD patients
Ventilation = MRI Static Ventilation Image; VDP = MRI ventilation defect percentage;
T2* = MRI free induction decay time constant; ADC = MRI apparent-diffusion-coefficient;
LmD = MRI mean-airway-length-scale; Lm = MRI mean-linear-intercept;
COPD-1: VDP =6, T2* = 7 ms, ADC =0.50 cm2 s-1, LmD = 290 µm, Lm = 800 µm
COPD-2: VDP =17, T2* = 8 ms, ADC = 0.40 cm2 s-1, LmD= 270 µm, Lm = 680 µm
COPD-3: VDP = 17, T2* = 9 ms, ADC = 0.40 cm2 s-1, LmD= 290 µm, Lm = 760 µm
Table 3: 3He MRI Parenchyma Measurements
Parameter (SD)
COPD-1
COPD-2
VDP, %
6
17
T2* (ms)
7 (5)
8 (5)
ADC (cm2/s)
0.50 (0.15)
0.40 (0.15)
LmD (µm)
290 (40)
270 (40)
Lm (µm)
800 (190)
680 (180)
SNR (SV)
30
25
SNR (b=0)
22
17
2
SNR (b=6.4s/cm )
6
4

COPD-3
17
9 (5)
0.40 (0.15)
290 (40)
760 (170)
30
20
6

COPD=COPD ex-smoker; VDP = ventilation defect percentage; T2*= free induction decay
time constant; ADC = apparent diffusion coefficient; LmD = mean airway length scale; Lm
= mean linear intercept estimate; SV = static ventilation; SNR = signal to noise ratio.
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DISCUSSION
In this proof-of-concept study, we investigated the feasibility of undersampling in imaging
and diffusion-weighted directions for potential use as a clinical tool. In a single 3He breathhold we were able to obtained static ventilation SV, T2*, ADC and morphometry maps
using 3He diffusion-weighted lung MRI in a single 16 sec breath-hold. Further, we
demonstrated that this acceleration scheme may be applied to

129

Xe imaging in order to

acquire whole lung ADC and morphological measurements in a single breath-hold, without
significant penalty to imaging information. In both nuclei, this acceleration can help save
up to two gas doses, decrease MRI scan time, and make the scan more tolerable for a patient
with lung disease.
By acquiring VDP/T2*/ADC/morphometry estimates during a single 3He scan, we
eliminate the need for two separate static ventilation and diffusion-weighted scans. The
3

He T2*-results suggested that T2* values were in the 7-9ms interval for severe emphysema

patients; 3He MRI T2* values have previously been measured in young healthy volunteers
on 3T GE (7±1.4ms) 32 and Philips (10.8±1.8ms) MRI systems.29 The mean T2* values we
reported were in the same range (7-9 ms), and therefore, the free induction decay estimates
we generated were likely physiologically realistic for the age and disease status of the
participants in this study. Likely, T2* estimates depend on alveolar surface-to-volume ratio
and, therefore, can be potentially used as a biomarker. Another potential role for T2*
mapping is signal correction. The SNR of static ventilation images, which ranged between
25 and 30, was more than adequate for VDP calculations and can be generated alongside
ADC values in a single rapid breath-hold.4 Moreover, the SNR we observed was typical
for multi b-value diffusion-weighed data acquired without acceleration.33 Thus, no special
denoising procedure was required prior to regularized reconstruction.
In order to validate this acceleration method, we conducted a sub-study with fully-sampled
129

Xe data. For all participants the mean ADC/ADCA values as well as Lm/LmA values were

not significantly different between acquisition methods (all p>.4). For the never-smoker
subgroup, a mean difference of 14%/12% was observed between the fully-sampled and the
accelerated approach for the ADC and Lm values, respectively and this difference was not
significant. For the COPD subgroup, a mean difference of 12%/8% was observed between
the fully-sampled and the accelerated approach for the ADC and Lm values, respectively
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and this was not significant. AATD subject results have confirmed that ADC/Lm MRI
estimates can be obtained in a single 16 sec breath-hold with the accelerated method.
Figure 2 shows that there is a difference between right and left lung in a COPD patient.
This is likely due to volume mismatch between the multiple-b value breath-hold coregistered images. If this is indeed the cause, this highlights the importance of a single
breath method for multiple-b value collections. Acceleration provides numerous
advantages for difficult clinical cases (by limiting the number of breath-holds required in
respiratory-compromised patients), for reduction of costs and for reduction of image
analysis requirements that stem from multiple breath-hold scans. For example, by reducing
the need for up to 5 different contrast gas breath-holds, the cost was reduced from
approximately $US 1200 to $US 200 for the gas contrast which is in the same cost range
as blood-based contrast agents. The time required to acquire the data is also reduced from
approximately 40 minutes to 10 minutes. Both of these savings combine and result in
substantial time and dollar cost savings as well as improved patient comfort and
safety/tolerability.
In this development study, we acknowledge a number of important study limitations,
including potential errors introduced into the fully-sampled data from multiple breathholds, as well as possible errors introduced because of low SNR. When separate breathholds are employed, image co-registration is required to ensure voxel-wise spatial
agreement between images. Unfortunately, co-registration results are not always accurate,
and this further highlights the need for, and importance of a single breath method for
multiple-b value acquisitions. We also recognize and acknowledge that for maximum bvalue images, SNR is less than the Rose criteria of SNR=5,34 which serves as a general
guide for image quality. However, this is an expected signal reduction due to the strong
diffusion attenuation for the patients with severe emphysema (Figure 1C, top panel).
Nevertheless, for larger b-value images, such as the b=6.4s/cm2 image, the relative values
are low compared to the lower b-value images so the influence on curve fitting is also low.
Certainly, low SNR images must also be considered as a limitation, however, new
polarization methods onboard commercially-available turnkey systems have recently
increased

129

Xe polarization levels (~40% polarization of a 400ml volume in 15-20

minutes) with the result being substantially improved image quality and SNR. We also
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recognize that for this study, we used D, α and LmD values of best-fit and did not collect
statistics on the fitting error/residual to exclude pixels. Finally, Eqn. [8] was not validated
with histology or morphometry methods and this is in contrast to Eqn. [7].23 However, we
note that Eqn. [8] was used only to validate the proposed acceleration method
reconstruction by applying retrospective k-space under-sampling to the multiple breathhold data so this would not likely influence the reliability of the accelerated diffusionweighted multi b-value 3He MRI method.
Accelerated

129

Xe MRI provides a way to generate alveolar morphometry estimates to

regionally characterize emphysema and airspace enlargement in patients with COPD and
AATD in a single breath-hold scan using a single gas dose. This means that multi-breath
methods (which are not as cost-efficient and may lead to lung volume variability and
patient distress or fatigue) or longer duration scans are no longer required and can be
replaced with accelerated methods. The emphysema biomarkers obtained for this pilot
study in COPD patients are the first demonstration of this acceleration (7x) method.

100

REFERENCES
1.
Collaborators USBoD. The state of us health, 1990-2010: Burden of diseases,
injuries, and risk factors. JAMA. 2013;310(6):591-606.
2.
Yablonskiy DA, Sukstanskii AL, Woods JC, et al. Quantification of lung
microstructure with hyperpolarized 3He diffusion MRI. J Appl Physiol. 2009;107(4):125865.
3.
Mugler JP, 3rd, Altes TA. Hyperpolarized 129Xe MRI of the human lung. J Magn
Reson Imaging. 2013;37(2):313-31.
4.
Kirby M, Svenningsen S, Owrangi A, et al. Hyperpolarized 3He and 129Xe MR
imaging in healthy volunteers and patients with chronic obstructive pulmonary disease.
Radiology. 2012;265(2):600-10.
5.
Kaushik SS, Cleveland ZI, Cofer GP, et al. Diffusion-weighted hyperpolarized
129Xe MRI in healthy volunteers and subjects with chronic obstructive pulmonary disease.
Magn Reson Med. 2011;65(4):1154-65.
6.
Kaushik SS, Robertson SH, Freeman MS, et al. Single-breath clinical imaging of
hyperpolarized 129xe in the airspaces, barrier, and red blood cells using an interleaved 3D
radial 1-point Dixon acquisition. Magn Reson Med. 2016;75(4):1434-43.
7.
Ouriadov A, Farag A, Kirby M, McCormack DG, Parraga G, Santyr GE. Lung
morphometry using hyperpolarized (129) Xe apparent diffusion coefficient anisotropy in
chronic obstructive pulmonary disease. Magn Reson Med. 2013;70(6):1699-706.
8.
Chang YV, Quirk JD, Yablonskiy DA. In vivo lung morphometry with accelerated
hyperpolarized (3) He diffusion MRI: a preliminary study. Magn Reson Med.
2015;73(4):1609-14.
9.
Pike D, Mohan S, Ma W, Lewis JF, Parraga G. Pulmonary imaging abnormalities
in an adult case of congenital lobar emphysema. J Radiol Case Rep. 2015;9(2):9-15.
10.
Chan HF, Stewart NJ, Parra-Robles J, Collier GJ, Wild JM. Whole lung
morphometry with 3D multiple b-value hyperpolarized gas MRI and compressed sensing.
Magn Reson Med. 2017;77(5):1916-25.
11.
Abascal JFPJ, Desco M, Parra-Robles J. Incorporation of prior knowledge of the
signal behavior into the reconstruction to accelerate the acquisition of MR diffusion data.
ArXiv
e-prints
[Internet].
2017;
1702.
Available
from:
http://adsabs.harvard.edu/abs/2017arXiv170202743A.
12.
Xu X, Norquay G, Parnell SR, et al. Hyperpolarized 129Xe gas lung MRI–SNR
and T2* comparisons at 1.5 T and 3 T. Magn Reson Med. 2012;68(6):1900-4.
101

13.
Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: dynamic MRI
with high frame rate exploiting spatiotemporal correlations. Magn Reson Med.
2003;50(5):1031-42.
14.
Jung H, Ye JC, Kim EY. Improved k-t BLAST and k-t SENSE using FOCUSS.
Phys Med Biol. 2007;52(11):3201-26.
15.
Sumpf TJ, Uecker M, Boretius S, Frahm J. Model-based nonlinear inverse
reconstruction for T2 mapping using highly undersampled spin-echo MRI. J Magn Reson
Imaging. 2011;34(2):420-8.
16.
Shin PJ, Larson PE, Ohliger MA, et al. Calibrationless parallel imaging
reconstruction based on structured low-rank matrix completion. Magn Reson Med.
2014;72(4):959-70.
17.
Haldar JP. Low-rank modeling of local k-space neighborhoods (LORAKS) for
constrained MRI. IEEE Trans Med Imaging. 2014;33(3):668-81.
18.
Lee D, Jin KH, Kim EY, Park SH, Ye JC. Acceleration of MR parameter mapping
using annihilating filter-based low rank hankel matrix (ALOHA). Magn Reson Med.
2016;76(6):1848-64.
19.
Goldstein T, Osher S. The Split Bregman Method for L1-Regularized Problems.
SIAM J Imaging Sci. 2009;2(2):323-43.
20.
Guo F, Yuan J, Rajchl M, et al. Globally optimal co-segmentation of threedimensional pulmonary 1H and hyperpolarized 3He MRI with spatial consistence prior.
Med Image Anal. 2015;23(1):43-55.
21.
Parra-Robles J, Marshall H, Hartley RA, Brightling CE, Wild JM. Quantification
of lung microstructure in asthma using a 3He fractional diffusion approach [abstract].
ISMRM 22nd Annual Meeting. 2014:3529.
22.
Berberan-Santos MN, Bodunov EN, Valeur B. Mathematical functions for the
analysis of luminescence decays with underlying distributions 1. Kohlrausch decay
function (stretched exponential). Chemical Physics. 2005;315(1-2):171-82.
23.
Ouriadov A, Lessard E, Sheikh K, Parraga G, Canadian Respiratory Research N.
Pulmonary MRI morphometry modeling of airspace enlargement in chronic obstructive
pulmonary disease and alpha-1 antitrypsin deficiency. Magn Reson Med. 2018;79(1):43948.
24.
Ouriadov A, Lessard E, Guo F, et al. Accelerated Diffusion-weighted 129Xe MRI
Morphometry of Emphysema in COPD and Alpha-1 Antitrypsin Deficiency Patients
[abstract]. ISMRM 25th Annual Meeting, Honolulu, Hawaii, USA. 2017([abstract]):1763.
25.
Ouriadov A, Farag A, Kirby M, McCormack DG, Parraga G, Santyr GE.
Pulmonary hyperpolarized (129) Xe morphometry for mapping xenon gas concentrations
102

and alveolar oxygen partial pressure: Proof-of-concept demonstration in healthy and
COPD subjects. Magn Reson Med. 2015;74(6):1726-32.
26.
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur
Respir J 2005;26(2):319-38.
27.
Miller G, Altes T, Brookeman J, De Lange E, Mugler Iii J. Hyperpolarized 3He
lung ventilation imaging with B 1-inhomogeneity correction in a single breath-hold scan.
Magn Reson Mater Phys Biol Med. 2004;16(5):218-26.
28.
Kirby M, Pike D, McCormack D, et al. Longitudinal Computed Tomography and
Magnetic Resonance Imaging of COPD: Thoracic Imaging Network of Canada (TINCan)
Study Objectives. J COPD F. 2014;1(2):200-11.
29.
Dominguez-Viqueira W, Ouriadov A, O'Halloran R, Fain SB, Santyr GE. Signalto-noise ratio for hyperpolarized (3)He MR imaging of human lungs: a 1.5 T and 3 T
comparison. Magn Reson Med. 2011;66(5):1400-4.
30.
Kirby M, Heydarian M, Svenningsen S, et al. Hyperpolarized 3He magnetic
resonance functional imaging semiautomated segmentation. Acad Radiol. 2012;19(2):14152.
31.
Zach JA, Newell Jr JD, Schroeder J, et al. Quantitative CT of the Lungs and
Airways in Healthy Non-Smoking Adults. Investigative radiology. 2012;47(10):596.
32.
Deppe MH, Parra-Robles J, Ajraoui S, et al. Susceptibility effects in hyperpolarized
3He lung MRI at 1.5T and 3T. J Magn Reson Imaging. 2009;30(2):418-23.
33.
Paulin GA, Ouriadov A, Lessard E, Sheikh K, McCormack DG, Parraga G.
Noninvasive quantification of alveolar morphometry in elderly never- and ex-smokers.
Physiol Rep. 2015;3(10).
34.
Rose A. The sensitivity performance of the human eye on an absolute scale. J Opt
Soc Am. 1948;38(2):196-208.

103

Appendix C - Advanced Pulmonary MRI to Quantify Alveolar and Acinar Duct
Abnormalities: Current Status and Future Clinical Applications
Appendix C is a review article presenting a historical overview of measurements of
alveolar and acinar duct abnormalities, from ex vivo studies to current in vivo
measurements, as utilized in Appendix A and Appendix B.
The contents of this chapter have previously been published in Journal of Magnetic
Resonance Imaging and permission to reproduce the article was granted by John Wiley
and Sons and is provided in Appendix C.
A Westcott, DG McCormack, G Parraga and A Ouriadov. Advanced pulmonary MRI to
quantify alveolar and acinar duct abnormalities: Current status and future clinical
applications. 10.1002/jmri.26574.
OVERVIEW
Chronic diseases of the lung frequently involve parenchymal tissue destruction and/or
fibrosis, terminal airspace enlargement, bronchiectatic airways and emphysematous
damage. Such chronic lung diseases include but are not limited to, interstitial lung disease
and fibrosis, chronic obstructive pulmonary disease (COPD), bronchopulmonary dysplasia
(BPD) related to extreme preterm birth, bronchiolitis obliterans related to lung transplant
and emphysema related to alpha-one antitrypsin deficiency (AATD). The development of
new therapies and the longitudinal monitoring of disease progression and response to
therapy in patients has been challenging because currently there are no clinically-available,
direct, non-invasive in vivo measurements of the lung tissue pathologies that
mechanistically drive disease initiation and progression. To address this serious clinical
and knowledge gap, highly sensitive and specific measurements of lung parenchyma
abnormalities, are required. In this review, we focus on obstructive lung diseases such as
COPD and BPD and review currently used ex vivo measurement tools including
histological and micro-CT measurements of biopsy samples. We also summarize emerging
pulmonary magnetic resonance imaging (MRI) methods that provide non-invasive in vivo
measurements of the terminal bronchioles and acinar duct geometry and morphology. We
discuss important new findings related to these developments, as well as future research
directions and clinical opportunities.
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RATIONALE: CLINICAL GAPS AND UNANSWERED QUESTIONS
For over 7 decades, the spirometry measurement of the forced expiratory volume in 1s
(FEV1), first invented in the 1800s,1 has remained the clinical measurement tool for
diagnosing chronic lung disease and for informing clinical management of patients over
time. Unfortunately, it is well-understood that FEV1 is insensitive to changes in the
parenchyma and small airways that are now believed to be the sites where chronic lung
disease initiates.2,

3

Moreover, parenchymal changes that alter the acinar ducts and

diminish the surface area for gas exchange are currently clinically measured using the
diffusing capacity of the lungs for carbon monoxide (DLCO). While DLCO measurements
are relatively inexpensive and straightforward to acquire, rigorous quality assurance of
equipment is required and even in frequently and expertly calibrated units, DLCO
measurements can be highly variable over time in patients4 which has effectively limited
its use in longitudinal studies.5

As an alternative, CT lung density and airway

measurements may be qualitatively or quantitatively evaluated6 although the combination
of the limited spatial resolution of thoracic CT (1mm isotropic) and radiation burden does
not support the use of CT for longitudinal or serial investigations, especially in young or
middle-aged patients.

Unfortunately, therefore, there remain significant gaps in our

understanding of how chronic lung disease initiates and progresses at the level of the acinar
ducts and terminal bronchioles. Moreover, it is difficult if not impossible to sensitively
measure response to therapy in patients.
HISTORICAL FRAMEWORK
Histology and Stereology
Some of the earliest understandings of lung disease pathogenesis stemmed from the pivotal
work of Leopold and Gough,7 over six decades ago. Their histological evaluation of 140
post-mortem emphysema samples (all but 10 male) were fixed under inflation and
compared with normal post-mortem findings. They made qualitative observations using
light microscopy of two-dimensional fixed samples which were ground-breaking; using
this approach, they made the first descriptions of the pathogenesis of emphysema in
relation to inflammation, bronchiolar caliber and emphysematous airspace enlargement.
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This seminal work and questions about the underlying physiology being probed by the
DLCO measurement motivated the development of three-dimensional lung morphometry
approaches and measurements based on two-dimensional cross- sectional histology
samples, by a number of groups and pioneered by Weibel, Ochs and colleagues.8, 9 As
shown in Figure 1, the overall three-dimensional structure of the lungs may be discerned
and measured using stereology methods.10, 11 Stereological measurements of excised lung
sections include, through-point counts, intersect counts and transect-counting, from which
an estimation of lung volume, surface area or mean linear intercept (Lm) can be made.12-14
While this approach has been fundamental to our understanding of lung disease
pathogenesis, unfortunately, it relies on excised lung tissue from post-mortem or postsurgical samples and thus this is limited to ex vivo analyses.

This certainly limits

longitudinal evaluations and hence this approach tends to focus on single time-point or
cross-sectional studies.
Micro-Computed tomography (CT)
The concept of micro-CT was first developed in the early 1980s,15-17 where this method
was employed by material scientists for imaging the internal structures of small objects.
Some of these early conceptual developments were commercialized in the early 1990s18, 19
and scanners that typically comprised of an X-ray source (focal diameter <100 µm) and a
thin x-ray detector were used to enable ex vivo and small animal in vivo samples
measurements. In fact, currently used micro-CT in combination with synchrotron radiation
provides images with approximately 10µm isotropic spatial resolution.20

Turn-key,

commercially available micro-CT systems have been employed to visualize and quantify
lung tissue measurements in mice,21 rats,22-25 pigs26 and cadaveric human lung
specimens.20, 27, 28 Micro-CT has also been applied to study patient lung tissue samples, as
shown in Figure 1, and provides a way to generate high spatial resolution images of normal
and abnormal parenchyma tissue resected from patients.3 However, micro-CT scan speed
and the radiation doses needed to generate images with the spatial resolution required to
measure lung abnormalities means that the method is feasible mainly for ex vivo and
cadaveric or end-stage small animal model tissue measurements.29, 30
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Figure 1: Lung tissue histology and micro-CT images.
Top panels show histology slides for normal and COPD patient and scalar bar is 500 µm
adapted from Woods et al. 2006 Mag Reson Med.103 Bottom panels show micro-CT
images for normal and emphysematous tissue with scalar bar 1mm, adapted from Watz et
al. 2005 Radiology.27

Thoracic CT
Important pathological observations made using ex vivo morphometry have led an
American Thoracic Society/European Respiratory Society (ATS/ERS) joint task force to
consider this approach as the gold standard for evaluating clinical interventions, severity
of disease and response to treatment.31 Translating such ex vivo findings to inform clinical
treatment decisions and disease monitoring requires in vivo, non-invasive measurements
such as provided using clinical thoracic x-ray computed tomography (CT). CT was first
used for pulmonary exams in the late 1970s, and this led to a number of studies of COPDrelated emphysema studies.32-36

For over three decades now, low dose, multi-detector
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thoracic CT has provided this opportunity in patients with a wide variety of chronic lung
diseases.37-40 In particular, thoracic CT provides a way to visualize the large airways and
provide measurements such as wall thickness and lumen diameter in vivo. Due mainly to
dose and to spatial resolution limitations, it is typically possible to segment and measure
airways to the ~7th generation. Despite these spatial resolution limits, CT provides
macroscopic quantitative measures which indirectly informs on the microstructure within
a voxel, based on the premise that a voxel near -1000 Hounsfield Units (HU) contains
minimal parenchymal tissue. Quantitative measures that are commonly used include the
relative area < -950 HU (RA950), the 15th percentile HU and slope calculated from low
attenuating clusters.41-43 In addition to CT emphysema measurements, CT may also be used
to evaluate lung surface area to volume ratios.44 The advent and development of thoracic
CT has provided enormous clinical and research value for in vivo lung measurements, but
its use is still limited because of radiation exposure concerns in patients and because of the
fundamental spatial resolution of method itself.
HYPERPOLARIZED NOBLE GAS MRI
Overview
Recently, hyperpolarized noble gas magnetic resonance imaging (MRI) has been employed
to visualize and measure pulmonary structure and function in vivo in patients. The
pulmonary hyperpolarized gas MRI era started with the publication of mouse lung

129

Xe

MRI by pioneers in the field of hyperpolarization physics.45 The original observations led
to the development of inhaled noble gas diffusion-weighted measurements in animal
models of emphysema46 and in patients with COPD.47 Because serial monitoring is critical
gap for small animal and patient studies, non-invasive inhaled hyperpolarized magnetic
resonance imaging (MRI) has emerged as a possible alternative or complementary method
for evaluating lung microstructure and function.48,

49

Importantly, during a 10-15s

breathhold, diffusion-weighted pulse sequences may be employed to determine the
apparent diffusion coefficient (ADC) of 3He47 and 129Xe50 gases, both of which have been
measured in COPD patients with emphysema51 and in AATD patients.52 The 3He MRI
ADC was shown to be highly reproducible48, 53 and to correlate with DLCO,54 reflecting
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regional emphysema.55

MRI diffusion-weighted pulse sequences provide maps and

regional ADC measurements that reflect the Brownian motion of the inhaled gas that is
restricted within the airways and alveoli.56 Because 3He in particular and 129Xe to a lesser
extent is inert, its displacement reflects the size of the alveolar structures that restrict its
movement. As such, pulmonary MRI ADC values provide non-invasive estimates of
alveolar dimensions; these have been used to measure the microanatomical abnormalities
associated with emphysema in COPD.47, 55, 57-63
It is reasonable to ask the question: Why MRI in patients with obstructive lung disease?
MRI has been used to investigate emphysematous changes in current and ex-smokers64-66
with COPD and to monitor potential lung regrowth in rodents67 and lung cancer patients.68,
69

The relationship of in vivo MRI estimates and histological measurements in excised

tissues were also determined.70,

71

These previous results have generated a strong

foundation for the optimization and strategic clinical research application of MRI in
patients, to directly measure treatment efficacy and help accelerate the development of
novel therapies including cell-based and whole organ replacement therapy. Therefore, as
there have been a number of thorough reviews on the history, technological background
and development of hyperpolarized gas MRI,72-74 this review will focus on the emerging
sub-field of hyperpolarized gas morphometry, and the unique role it can play in guiding
patient management.
MRI Apparent Diffusion Coefficients
Estimates of the self-diffusion coefficient of liquids or gases are based on the Einstein
equation:
D=

 r 2
,
2nt d

where D is a self-diffusion coefficient, <r>2 is the mean square displacement of a Brownian
molecule, n is a dimension (n=1, 2, 3) and td is the diffusion observation time. If D does
not depend on the diffusion observation time and the direction of diffusion, there is by
definition, free isotropic diffusion which may be characterized using Gaussian
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[1]

distributions.75 However, liquid or gas diffusion inside a confined media may deviate from
the free isotropic diffusion, and in such cases, D is a function of td, and is more
appropriately described as an Apparent Diffusion Coefficient (ADC), which depends on
both td and the geometry of the confining medium. MRI ADC measurements typically
require only two data points, one with and another without a single-direction diffusionsensitizing pulse. D values may also depend on the direction of the diffusion measurement
or is anisotropic so that diffusion in one direction is more rapid than in another direction.
An example of anisotropic diffusion is a gas molecule diffusion inside the Weibel model
of an acinar duct airway,76 shown in Figure 2 with the added assumption of non-permeable
walls75 and infinitely long ducts. In such a model, the diffusion measured along the duct
direction or a longitudinal diffusion (with anisotropic diffusion coefficient (DL)) should
approach free diffusion. However, the diffusion measured perpendicular to the duct axis
direction, or a transverse diffusion (with anisotropic diffusion coefficient (DT)) is restricted
by that dimension. Restricted or non-free diffusion means that diffusing gas molecules
start to interact with the duct walls, the transverse diffusion becomes restricted and the
measured DT should be less than DL based on Eq [1]. This intuitive example demonstrates
that gas molecules can be utilized with MRI to probe the micro-geometry of alveoli with
submillimeter spatial resolution even when voxels are significantly larger in size. A
number of theories describing restricted diffusion features were published where the main
focus was extraction of geometric information, such as the size and shape of pores or
channels77-80 and the surface-to-volume ratio (S/V) of porous space.81, 82
Table 1: Typical MRI acquisition parameters
2D Diffusionweighted 3He MRI

TR/TE (ms)
Flip Angle
FOV (cm2)
Matrix size
Slice number
Orientation
Voxel size (mm3)
b-value (s/cm2)
Diffusion time (ms)
Scan time (sec)
Cylinder (ref 85)

3.9/5.6
4o
40 x 40
128 x 80
7
Coronal
3.1 x 3.2 x 30
0, 1.6, 3.2, 4.8, 6.4
1.46
16
Yes
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3D Diffusionweighted
129
Xe MRI
11/10
VFA
40 x 40
128 x 80
7
Coronal
3.1 x 3.2 x 30
0, 12, 20, 30, 40
5
>16*
Yes

3D Diffusionweighted
129
Xe MRI
With CS AF=7
11/10
VFA
40 x 30
128 x 128
7
Coronal
3.1 x 3.2 x 30
0, 12, 20, 30, 45
5.2
>16
Yes

Single Compartment (ref
52)
Stretched Exponential (ref
90)

Yes

No

No

Yes

No

Yes

VFA= variable flipped angle; FOV=field of view; TR= relaxation time; TE=echo time
*16s for two b-values only. CS=compressed sensing, AF=acceleration factor.
Figure 2: Schematic for Weibel Acinar Duct cylindrical model
Cylinder model of acinar airways showing the two anisotropic diffusion coefficients: DL
representing diffusion parallel to the acinar airway and DT representing diffusion
perpendicular to the acinar airway. The dashed arrows show the directions of the two
anisotropic diffusion coefficients where R = external airway radius, r = internal airway
radius, h = alveolar sleeve depth and L = alveolar length. Adapted from Yablonskiy et al.
2002 PNAS (51).

MRI Sub-voxel Resolution Morphometry Modelling
To provide clinically-relevant measurements of alveolar sizes and geometries, MRI
morphometry was first proposed by Yablonskiy27 using hyperpolarized 3He MRI and
further developed by a team of pioneers in St Louis at Washington University.58, 61, 83-85
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MRI morphometry requires multiple-b value sampling (four different b-values or more) in
order to probe a wide range of the alveolar sizes. To model MRI diffusion measurements,
the Weibel model of the acinar duct was first employed and this resembles a long cylinder
that represents the terminal bronchiole with acini.

Using this specific geometry,

anisotropic diffusion coefficients DL and DT depend on the internal (r) and external (R)
radii of the acinar duct (Figure 2) in multi-b value measurements. Correlations between
clinically relevant alveolar estimates such as mean airspace chord length, alveolar surfaceto-volume ratio and MRI-derived r/R (shown in Figure 2) have been observed.86
Figure 3: Hyperpolarized 3He MRI Static Ventilation and Apparent Diffusion
Coefficient Maps and Thoracic CT
Ex-smoker with COPD: FEV1=32%pred, FEV1/FVC=28%pred, DLCO=37%pred, RA950 =
18%; and AATD patient: FEV1=61 %pred, FEV1/FVC=60%, DLCO=21%pred, RA950 = 31%;
MRI and thoracic CT with RA950 mask in yellow
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COPD = Ex-smoker with COPD, AATD: = Alpha-1 antitrypsin deficiency, Yellow pixels
on CT RA950 maps correspond to voxels < -950 Hounsfield Units.
Recently, an alternative to the cylinder model -the stretched exponential model was
developed and this approach does not assume any underlying geometry, and so this may
be used to fit any multi-b diffusion attenuation using general signal decay equations87 and
a dedicated mathematical framework.88 Because the stretched exponential model does not
assume any specific geometry for the acinar duct, MRI estimates based on this approach
still require validation with histological ground truth and with the morphometry estimates
based on the cylinder model.52 A major advantage of the stretched exponential model
approach is that it may be combined with compressed sensing89 to accelerate image
acquisition using under-sampling in the imaging and diffusion directions.90
Currently, a cylinder morphometry model is the most widely-used, and is histologicallyvalidated70 in patients and histology/micro CT-validated in animal models.71,

91-93

Although the cylinder model has a complete mathematical framework for both 3He and
129

Xe clinical/pre-clinical lung morphometry,85,

94, 95

most morphometry studies were

conducted with 3He gas. This is largely due to increased scan times needed for

129

Xe

measurements, which makes the stretched exponential model a promising alternative.
Figure 4 shows representative centre slice 3He morphometry and CT images obtained for
COPD, AATD and BPD patients.

The bottom panel shows MRI-derived Lm maps

generated for these patients all of whom show different emphysema patterns. For the
representative COPD patient, there was augmented ADC reflecting emphysema in the
apical lung regions (hotter colours indicate larger Lm values). The distribution of MRIderived Lm values were also in agreement with the regional distribution of CT RA950.
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Figure 4: Hyperpolarized 3He MRI-derived Lm and thoracic CT RA950 in patients with
COPD, AATD and BPD.
Top panel is ex-smoker with COPD; FEV1=126%pred, FEV1/FVC=63%, DLCO=62%pred,
RA950 = 11%, Lm = 500 µm; middle panel is AATD patient; FEV1=58%pred, FEV1/FVC=
41%, DLCO=50%pred, RA950 = 17%; Lm = 720 µm and bottom panel is BPD patient;
FEV1=36%pred, FEV1/FVC= 39%, DLCO= 76%pred, RA950 = 16%, Lm = 420 µm.

Yellow pixels on CT RA950 maps correspond to voxels < -950 Hounsfield Units.
Validation of MRI morphometry
All key preclinical and clinical findings using 3He/129Xe MRI are summarized in Table 2
which shows that MRI-derived lung morphometry has been directly compared with micro114

CT/histology-based estimates in small animal models. In Figure 4, the mean Lm for the
COPD patient was 500 µm, significantly greater than the mean Lm estimate reported in
elderly never-smokers,96 which suggests that Lm can be used as emphysema biomarker and
can be directly compared with histological values. In mouse studies, MRI-derived Lm
values were in agreement with stereological measurements from lung histology and CT
measurements.91 A small animal model of mild emphysema was also investigated using
129

Xe MRI morphometry and histological measurements and a systematically increased Lm

was reported.93 In patient studies, Lm values were also shown to agree with stereological
measurements.85 Excellent correspondence between MRI based Lm estimates and the
histology mean linear intercept estimates was confirmed.70, 71 Although there has not been
a direct comparison of

129

Xe morphology measurements to histology, there has recently

been comparisons of 129Xe to 3He derived measures.97
Table 2: MRI-derived and Histology Mean Linear Intercept (Lm) values in small animal
models and patients

3He

Clinical*:
Normal lung
Normal lung
Mild emphysema
Mild emphysema
Severe emphysema
Severe emphysema

Mean Linear Intercept (Lm)
129Xe MRI
Histology

MRI

100 µm
170 µm
250 µm
360 µm
590 µm
670 µm

105 µm
140 µm
240 µm
360 µm
590 µm
660 µm

-

Histology
-

Small animal models:
Healthy micea
60±4 µm
52±2 µm
Sham miceb
66±5 µm
64±9 µm
b
Pneumonectomy mice
68±3 µm
65±9 µm
c
Control rats
79±12 µm
70±15 µm
Irradiated ratsc
54±17 µm
57±12 µm
d
Healthy rats
110±7 µm
80±7 µm
d
Emphysematous rats
130±9 µm
100±4 µm
*Data from (85); aData from (91) bData from (67) cData from (71) d Data from (93)
APPLICATIONS
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Table 3 summarizes recent findings using MRI ADC and morphometry values in patients
with COPD, BPD, lung cancer radiation-induced lung injury, post-surgical lung regrowth
and lung transplant.

Table 3: Summary of MRI Morphometry Studies by Disease foci of interest
Application

Nuclei

Patient-based Study
Literature References

Volunteers

3He

(103), (85), (97), (64), (90),
(52), (93), (99), (97)

129Xe

(65), (97), (129)

3He

(13), (103), (85), (104),
(84), (97)

129Xe

(65), (97), (129)

AATD

3He

(52), (99)

BPD

3He

(105)

CF

129Xe

(101)

Lung Growth

3He

(68)

RILI

3He

COPD

Small-Animal Model Study
Literature References
(93), (92)
(126)

(93)

(67)
(102)

129Xe

(71)

COPD
Figure 4 shows hyperpolarized 3He MRI Lm maps and CT for patients with emphysema
related to COPD and alpha-1 antitrypsin deficiency. The MRI-derived Lm map generated
for the AATD subject shows two well-defined regions: 1) apical lung with normal Lm
values and, 2) basal lung with abnormally large Lm values, suggesting severe emphysema
(Lm > 500 µm). Thoracic CT density masks show good quantitative and spatial agreement
with MRI regions with augmented Lm values. MRI morphometry has also clearly revealed
emphysematous changes in current and ex-smokers,64-66 congenital lobar emphysema,98
normal lung aging,96 as well as for evaluating emphysema in AATD patients52, 99 and
monitoring AATD patient response to augmentation therapy.100
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129

Xe MRI morphometry

has been piloted and compared in a small group of COPD patients and healthy volunteers65
with mean MRI-derived Lm values in the range of 220-253 μm and 410 ± 90 μm,
respectively.101 Finally, hyperpolarized gas diffusion-weighted MRI has been clinically
approved for use in the United Kingdom56, 102-104 and this will dramatically increase the
number of cases that can be used as exemplars of the utility of the method.
Bronchopulmonary Dysplasia (BPD)
Extreme prematurity at birth (<28 weeks gestation) commonly results in neonatal intensive
care and mechanical ventilation due to respiratory distress syndrome because of limited or
no lung surfactant and incomplete lung development. Ventilator-associated lung injury is
also possible and extreme prematurity of the lung themselves cause abnormal and irregular
lung growth (BPD). In neonates with a clinical diagnosis of BPD, monitoring of lung
development throughout the course of the patient’s life may guide the type and timing
oftreatment, as well as provide insight into lung development in BPD. Hyperpolarized
noble gas MRI morphometry has been used to observe the abnormal development of the
acinar ducts as with BPD patients,105 and was shown to be a promising method for
longitudinal monitoring. Figure 4 provides an MRI-derived Lm map and CT with lung
attenuation values <-950 HU shown in yellow for a patient with BPD. The heterogeneous
MRI-derived Lm distribution is consistent with the heterogeneous distribution of the CT
low-density areas. Importantly, this approach was previously validated using histology in
clinical and small animal studies, as summarized in Table 2, providing credence and
evidence of feasibility for the use of MRI morphometry in young patients with BPD in
whom repeated CT imaging is not practical for radiation burden reasons.
Radiation-induced lung injury
Radiation-induced lung injury (RILI) remains a major dose-limiting factor for radiotherapy
treatment of the lung cancer.

Radiation pneumonitis or inflammation is commonly

observed in patients at ~3 to 12 weeks post-irradiation due to cytokine induction and
inflammation related to the radiation therapy. Late stage post-radiation pulmonary effects
include parenchymal fibrosis and this typically develops 6 to 24 months post-radiation
therapy and manifests as an irreversible decrease in lung compliance and decreased lung
117

volume which are characteristic of a restrictive or fibrotic pulmonary phenotype. Both
early and late post-radiation pulmonary effects have been well-investigated106-108 but there
remains an urgent need for new regional lung measurements of early post-radiation
changes, in order to improve patient outcomes. A number of longitudinal clinical studies
evaluated lung microstructure following radiotherapy treatment.109-114 These studies have
reported differences in ADC values in patients with RILI compared to controls, along with
3

He static lung ventilation defects. RILI-induced fibrosis in rats showed102 that ADC values

in regions of fibrosis were lower compared to healthy regions. The earliest stages of
radiation-pneumonitis and RILI was also investigated using

129

Xe MRI morphometry in

rats. This work revealed quantitative morphological changes at the alveolar level as early
as two weeks post-radiation71 while MRI-based Lm, estimates were consistent with Lm
changes measured using histology in rats sacrificed at the end of the study.
Adult Lung Regrowth
One potential clinical application of MRI morphometry is the evaluation and
characterization of lung growth in newborns and children as well as in adults, post-surgery.
The observation and assessment of lung regrowth in adults68 and in small animal models67
demonstrated this clinical potential for cases where MRI is a good alternative for noninvasive assessment of lung structure and function. In the new field of cell-based
replacement therapies and whole organ regeneration,115,

116

non-invasive MRI

morphometry provides a non-invasive way to serially measure lung growth as well as the
biomechanical and functional properties.

For example, 3He MRI morphometry was

recently used to track lung growth over 30 days using MRI Lm estimates and changes in
the alveolar density.67
Lung Transplant
Bronchiolitis obliterans syndrome (BOS), or obstructive chronic lung allograft dysfunction
(CLAD), is loss of lung function due to airway remodeling and fibrosis following lung
transplantation.117 Clinically, BOS is characterized using measurements of gas-trapping,
bronchiectasis and hyperinflation and thoracic CT follow-up is commonly employed posttransplantation to monitor lung structural changes. More than 10 years ago, hyperpolarized
118

3

He MRI was piloted in post-transplant patients to detect and measure ventilation defects

due to BOS.118, 119 While MRI morphometry has not yet been piloted in these patients, it
will certainly provide a sensitive, non-invasive means of measuring changes in the lung
parenchyma and perhaps early warnings of BOS in post-transplant patients.

CHALLENGES AND LIMITATIONS
A summary of the challenges, limitations and strengths associated with 3He and 129Xe lung
morphometry MRI are briefly outlined in Table 4. Some of the limitations of
hyperpolarized noble gas MRI relate mainly to infrastructure availability and the
complexity of the analysis that has limited its use at major clinical centers. While 3He
availability and cost is also a limitation,120 as an alternative,

129

Xe gas provides both

availability and cost effectiveness121, 122 while enabling imaging measurements that are
similar to and perhaps more sensitive to airway obstruction than 3He.55, 63, 123, 124 As well,
129

Xe is modestly soluble in biological tissues and blood, which permits simultaneous

ventilation-perfusion and blood-gas tissue barrier imaging.125, 126 However,

129

Xe MRI

whole lung three-dimensional morphometry is still very challenging88, 127 and this has led
to the development of rapid image acquisition and reconstruction techniques as well as
advanced transmit-receive MRI hardware.127, 128 Recently, the feasibility of single breathhold, whole lung morphometry with hyperpolarized 3He using parallel imaging was
demonstrated127 in four asthma patients with a reduction in total acquisition time of up to
10 seconds; morphometric estimates with and without parallel imaging demonstrated good
agreement. Another single breath-hold 3He/129X whole lung morphometry approach using
compressed sensing with an acceleration factor similar to parallel imaging was
demonstrated in healthy volunteers and COPD patients.88,

97

Recently, a compressed

sensing approach90 was developed that combined undersampling in both spatial and
diffusion-sensitizing directions; this work underscores the role of continuous optimization
of compressed sensing and parallel imaging to reduce acquisition times which may help
increase clinical uptake.

119

Table 4: Challenges, Limitations and Opportunities
3

Challenges

129

He MRI
High cost, limited supply

Xe MRI
Low gamma = lower SNR than 3He
MRI

No pathway for clinical translation
Slower lung filling and gas diffusion
No pathway
translation

Limitations

for

commercial
Advanced MRI hardware such as high
gradient strength and receive phase
arrays needed

Cannot be mixed with oxygen or Cannot be mixed with oxygen or used
used
for
free
breathing for dynamic free-breathing patient
measurements in patients
measurements
Inert, not soluble in lung tissue and
blood
Pulse sequences result in mechanical
vibrations leading to acoustic effects

Opportunities

High image SNR

Natural abundance of 129Xe isotope

Fast lung filling

Large volume, high polarization, rapid
production 129Xe polarizers
Solubility in tissue and blood allows for
pulmonary gas, barrier, blood imaging
and brain measurements.
Approved for clinical use UK

ROLE IN FUTURE
Patients with chronic lung disease typically require treatment and monitoring over decades
as disease progression, lung maturation and aging ensues. Frequent, or at least annual
clinical evaluations are required to assess progressive disease, response to therapy and the
need for changes in therapy and other clinical management strategies. Until now however,
and in a few specific cases, thoracic imaging is not routinely used in the clinical work-up
or follow-up of patients with chronic lung disease. The application of MRI morphometry
methods and measurements in patients with COPD,51,

64, 65, 85, 96, 97, 103, 104, 129

cystic

fibrosis,101 BPD105 and AATD 52, 99 has well-demonstrated its clinical potential and opens
the door for more personalized and perhaps augmented therapy for these patients. For
120

example, in AATD patients, including those undergoing augmentation therapy or cellbased therapy, there is a potential clinical benefit because response to therapy can be
measured using MRI-derived Lm. Moreover, preclinical studies have demonstrated the
promising impact of stem cell-based therapies in small animal models mimicking BPD.130,
131

The evidence of alveolar growth and repair observed in the small animal models is now

driving early phase clinical trials for which MRI lung morphometry is an ideal efficacy and
safety measurement tool. Furthermore, the direct phenotyping of AATD, BPD and CF
patients with MRI-derived lung morphometry measurements holds promise for clinical
decision making in regard to lung transplant.

Certainly, MRI-derived morphometry

measurements are highly complementary to current clinical consensus guideline
measurement thresh-holds used to stratify patients to the transplant list.
Further development of MRI hardware including multiple receive array coils132 and
increasing clinical scanner gradient strength, as well as parallel imaging127 and compressed
sensing,88 will improve image quality and signal-to-noise ratios as well as decrease the data
acquisition time. This will provide a way to combine isotropic ventilation and diffusionweighting in a single breath-hold whole lung measurement. Another important step that
will enhance clinical utilization of

129

Xe MRI morphometry measurements is the

facilitation of new clinical research sites at pediatric hospitals including Cincinnati
Children’s Hospital (Cincinnati USA) and the Hospital for Sick Children (Toronto
CANADA).
In summary, following the pivotal ex vivo studies of Leopold and Gough7 and Weibel and
co-workers 8, hyperpolarized noble gas MRI provides new, non-invasive in vivo
measurements of the lung parenchyma that have been validated using histology. In future,
new 129Xe MRI methods will be developed to generate regional maps and biomarkers of
alveolar wall microstructure because

129

gas diffusion and in the blood.125,

133, 134

Xe has modest solubility in the tissue barrier for
This technological advance will certainly

accelerate in vivo longitudinal monitoring of lung biomarkers135 that have never before
been possible in patients.
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Project: ‘Designing a Model to Investigate Charge in Amorphous
Selenium Flat Panel X-Ray Detectors’

2015

Queen’s University
Undergraduate Research Assistant
Department of Mechanical and Materials Engineering
Supervisor: Dr. David Rival
Project: ‘Creating a Novel Refractive Index Matched Hydrogel
Model for 3D Fluid Flow Analysis’
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HONOURS AND AWARDS

2019

ISMRM Educational Stipend Award
ISMRM Annual Meeting 2019
Awarded to support the attendance of students, postdoctoral and
clinical trainees to present abstracts at the scientific meeting
$535 USD

2019

Canadian Thoracic Society Poster Competition
American Thoracic Society Annual Meeting
Selected as one of the Top 30 abstracts submitted to the American
Thoracic Society conference.

2018-

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to a full time graduate student for stipend support who has
maintained an average of 80% or more
$1,667 per term

2017- 2018

Western Graduate Research Scholarship
Department of Medical Biophysics, Western University
Awarded to a full time graduate student for stipend support who has
maintained an average of 80% or more
$1,500 per term

2018

ISMRM Educational Stipend Award
Joint Annual Meeting ISMRM-ESMRMB 2018
Awarded to support the attendance of students, postdoctoral and
clinical trainees to present abstracts at the scientific meeting
$525 USD

2015-2017

Dean’s Scholar
Queen’s University
Granted to Undergraduate Engineering students who obtain a
GPA of 3.5 or higher

2013

Queen’s University Excellence Scholarship
Queen’s University
Entrance scholarship based on high school grades of 90.0-94.9%
$2,000

PRESENTATIONS AND PRESENTATIONS
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A Peer Reviewed Journal Manuscripts
In Preparation (n=1)
1.

DPI Capaldi, C Ong-Ly, A Westcott, RL Eddy, F Guo, DG McCormack and G Parraga.
Hyperpolarized 3He MRI Biomarkers of Ventilation Defect Clusters: Comparison in
Chronic Obstructive Pulmonary Disease and Bronchiectasis. In preparation for
Academic Radiology.

Submitted (n=1)
1. A Westcott, DPI Capaldi, DG McCormack, A Ward, A Fenster and G Parraga. Chronic
Obstructive Pulmonary Disease: Thoracic CT Texture Analysis and Machine Learning
to Predict Pulmonary Ventilation. Submitted to Radiology February 26, 2019.
Accepted (n=4)
1. A Westcott, DPI Capaldi, A Ouriadov, DG McCormack and G Parraga.
Hyperpolarized 3He MRI ventilator apparent diffusion coefficient of alpha-1
antitrypsin deficiency. JMRI 2018. DOI: 10.1002/jmri.26202.
2. A Westcott, F Guo, G Parraga and A Ouriadov. Rapid single-breath hyperpolarized
noble gas MRI-based biomarkers of airspace enlargement. JMRI 2018. DOI:
10.1002/jmri.26574
3. RL Eddy, A Westcott, GN Maksym, G Parraga and RJ Dandurand. Oscillometry and
Pulmonary Magnetic Resonance Imaging in Asthma and COPD. Physiological
Reports. DOI: 10.14814/phy2.13955.
4. A Westcott, DG McCormack, G Parraga and A Ouriadov. Advanced Pulmonary MRI
to Quantify Alveolar and Acinar Duct Abnormalities: Current Status and Future
Clinical Applications. JMRI 2018. DOI: 10.1002/jmri.26623.
B Peer Reviewed Published Conference Proceedings
Accepted (n=2)
1. A Westcott, DPI Capaldi, DG McCormack, A Fenster and G Parraga. Texture Analysis
of Thoracic CT to Predict Hyperpolarized Gas MRI Lung Function. SPIE Proceedings
(oral presentation).
2. JL MacNeil, DPI Capaldi, RL Eddy, A Westcott, AM Matheson, AL Barker, C OngLy,
DG McCormack and G Parraga. Development and Evaluation of Pulmonary Imaging
Multi-Parametric Response Maps for Deep Phenotyping of Chronic Obstructive
Pulmonary Disease. SPIE Proceedings (oral presentation).
B Peer Reviewed Conference Abstracts
Submitted (n=1)
1. RL Eddy, A Westcott, M Kirby, DG McCormack, G Parraga. CT Pulmonary Vessel
Volume in Ex-smokers with Normal FEV1. European Respiratory Society International
Congress 2019 Madrid, Spain September 28-October 2, 2019.
Accepted (n=21)
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1. A Westcott, DPI Capaldi, D McCormack, A Fenster and G Parraga. Machine Learning
for Lung Function Synthesis: Predicting MRI Ventilation from Thoracic CT. Imaging
Network of Ontario Symposium 2019.
2. RL Eddy, A Westcott, GN Maksym, DG McCormack and G Parraga. Can
Oscillometry Explain Differences Between 3He and 129Xe Ventilation Heterogeneity?
Imaging Network of Ontario Symposium 2019.
3. AL Barker, RL Eddy, AM Matheson, A Westcott, GR Washko and G Parraga. Is
Vascular Pruning Related to MRI Ventilation Defects in Bronchiectasis and COPD
Patients? Imaging Network of Ontario Symposium 2019.
4. JL MacNeil, DPI Capaldi, A Westcott, DG McCormack and G Parraga. Novel COPD
Multi-parametric Response Map Phenotypes. Imaging Network of Ontario Symposium
2019.
5. A Ouriadov, A Westcott, DG McCormack and G Parraga. Longitudinal Emphysema
Measurements in Patients using 3He and 129Xe MRI. Imaging Network of Ontario
Symposium 2019.
6. A Westcott, M Kirby, DG McCormack and G Parraga. Normal Thoracic CT in Exsmokers without COPD: Can Machine Learning Reveal Subclinical Disease? American
Thoracic Society Annual Scientific Meeting 2019 Dallas, TX, United States May 1722, 2019.
7. AL Barker, RL Eddy, AM Matheson, A Westcott, GR Washko and G Parraga.
Bronchiectasis, Vascular Pruning and Ventilation Defects in COPD and Bronchiectatic
Patients: Are They Related? American Thoracic Society Annual Scientific Meeting
2019 Dallas, TX, United States May 17-22, 2019.
8. JL MacNeil, DPI Capaldi, A Westcott, DG McCormack and G Parraga. Novel Multiparametric Response Map COPD Phenotypes. American Thoracic Society Annual
Scientific Meeting 2019 Dallas, TX, United States May 17-22, 2019.
9. C Ong Ly, A Westcott, I Dhaliwal, A Fenster, M Kirby and G Parraga. Can Machine
Learning and MRI Identify COPD Patients at Risk of Accelerated Progression?
American Thoracic Society Annual Scientific Meeting 2019 Dallas, TX, United States
May 17-22, 2019.
10. A Ouriadov, A Westcott and G Parraga. Feasibility of Longitudinal Emphysema
Measurements in COPD and Alpha-1 Antitrypsin Deficiency Using 3He and 129Xe
MRI. American Thoracic Society Annual Scientific Meeting 2019 Dallas, TX, United
States May 17-22, 2019.
11. A Westcott, A Ouriadov, RL Eddy, DG McCormack, M Kirby, G Parraga.
Compressed Sensing Hyperpolarized Noble Gas Ventilation MRI: Towards a
Maximum Clinically Acceptable Acceleration Factor. International Society for
Magnetic Resonance in Medicine Annual Scientific Meeting 2019 Montreal, Canada
May 11-16, 2019.
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12. C Ong-Ly, A Westcott, I Dhaliwal, A Fenster, M Kirby and G Parraga. Hyperpolarized
Ventilation MRI and Ensemble Machine Learning Predict Airflow Limitation
Worsening in Ex-smokers. International Society for Magnetic Resonance in Medicine
Annual Scientific Meeting 2019 Montreal, Canada May 11-16, 2019.
13. S Svenningsen, A Ouriadov, NB Konyer, RL Eddy, A Westcott, DG McCormack, M
Kjarsgaard, MD Noseworthy, P Nair and G Parraga. Two-site Reproducibility of
Hyperpolarized 129Xe MRI Ventilation in Severe Asthma: Implications for Multicenter
Clinical Studies. International Society for Magnetic Resonance in Medicine Meeting,
Montreal, QC, Canada
14. A Ouriadov, A Westcott, DG McCormack, G Parraga. Feasibility of 129Xe MRI
Morphometry Measurements with Acceleration Factors of 7 and 10. International
Society for Magnetic Resonance in Medicine Annual Scientific Meeting 2019
Montreal, Canada May 11-16, 2019.
15. RL Eddy, A Westcott, GN Maksym, DG McCormack, G Parraga. Differences between
3
He and 129Xe Ventilation Heterogeneity Explained Using Oscillometry. International
Society for Magnetic Resonance in Medicine Annual Scientific Meeting 2019
Montreal, Canada May 11-16, 2019.
16. AL Barker, A Westcott, RL Eddy, DG McCormack, G Parraga and A Ouriadov.
Feasibility of Single Breath-hold Isotropic Voxel 129Xe MRI in Patients. International
Society for Magnetic Resonance in Medicine Annual Scientific Meeting 2019
Montreal, Canada May 11-16, 2019.
17. A Westcott, DG McCormack and G Parraga. Texture Analysis of Thoracic CT to
Predict Hyperpolarized Gas MRI Lung Function. SPIE Medical Imaging Proceedings
(oral presentation).
18. JL MacNeil, DPI Capaldi, RL Eddy, A Westcott, AM Matheson, AL Barker, C OngLy,
DG McCormack and G Parraga. Development and Evaluation of Pulmonary Imaging
Multi-Parametric Response Maps for Deep Phenotyping of Chronic Obstructive
Pulmonary Disease. SPIE Medical Imaging Proceedings (oral presentation).
19. A Westcott, R Eddy, DPI Capaldi, H Young, DG McCormack and G Parraga,
Quantification of Hyperpolarized 3He MRI Ventilation Heterogeneity in asthmatics:
Surface area of ventilation clusters. International Society for Magnetic Resonance in
Medicine Meeting Proceedings 2018.
20. A Westcott, DPI Capaldi, A Ouriadov, DG McCormack and G Parraga, Longitudinal
Imaging Biomarkers of Severe Emphysema in AATD and COPD. London Health
Research Day 2018.
21. A Westcott, R Eddy DPI Capaldi, H Young, DG McCormack and G Parraga.
Quantification of Hyperpolarized 3He MRI Ventilation Heterogeneity in Asthmatics:
Surface Area of Ventilation Clusters. Robarts Research Retreat 2018.
C Poster Presentations (n=4)
1. A Westcott, R Eddy, DPI Capaldi, H Young, DG McCormack and G Parraga,
Quantification of Hyperpolarized 3He MRI Ventilation Heterogeneity in asthmatics:
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Surface area of ventilation clusters. International Society for Magnetic Resonance in
Medicine Meeting Proceedings 2018. (electronic poster)
2. A Westcott, DPI Capaldi, A Ouriadov, DG McCormack and G Parraga. Imaging
Biomarkers of Airspace Enlargement: Alpha-1 Antitrypsin Deficiency. London
Imaging Discovery Day 2018. (electronic poster)
3. A Westcott, DPI Capaldi, A Ouriadov, DG McCormack and G Parraga, A Novel
Magnetic Resonance Imaging Biomarker of Airspace Enlargement in Alpha-1
Antitrypsin Deficiency. London Health Research Day 2018. (traditional poster)
4. A Westcott. Designing a Model to Investigate Charge in Amorphous Selenium Flat
Panel X-Ray Detectors. Queen’s University Department of Physics Thesis Poster
Presentation, Kingston, Ontario, April 12, 2017. (traditional poster)
D Academic Reports (n=1)
1. A Westcott. Designing a Model to Investigate Charge in Amorphous Selenium Flat
Panel X-Ray Detectors. Queen’s University Undergraduate Thesis, Kingston,
Ontario, 2017.
PROFESSIONAL SOCIETIES
2017International Society for Magnetic Resonance in Medicine
Student Member
2018American Thoracic Society
Student Member
2018International Society for Optics and Photonics (SPIE)
Student Member
COMMUNITY ACTIVITIES
2017BIRC Deep Learning Club Co-coordinator
Co-coordinators: Rachel Eddy, Wenyao Xia, Patricia Johnson
Goal: Organize monthly seminars for introduction and exploration
of deep learning applications in medical research.
Responsibilities: Give presentations and organize a community for
deep learning.
2016-2017
Let’s Talk Science
Workshop Volunteer
Queen’s University
2014-2017
Mini Baja Design Team
Team Member
Queen’s University
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